# EDGAR Filing Document

**Accession Number:** 0001475922
**File Stem:** 0000950170-23-004155
**Filing Date:** 2023-2
**Character Count:** 143816
**Document Hash:** 096be79740d92665e5ae01b848c7807e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-004155.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0000950170-23-004155

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 17

**CONFORMED PERIOD OF REPORT**: 20230223

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230223

**DATE AS OF CHANGE**: 20230223

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Primerica, Inc.
- **CENTRAL INDEX KEY:** 0001475922
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **IRS NUMBER:** 271204330
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34680
- **FILM NUMBER:** 23660379

**BUSINESS ADDRESS:**
- **STREET 1:** 1 PRIMERICA PARKWAY
- **CITY:** DULUTH
- **STATE:** GA
- **ZIP:** 30099
- **BUSINESS PHONE:** 7703811000

**MAIL ADDRESS:**
- **STREET 1:** 1 PRIMERICA PARKWAY
- **CITY:** DULUTH
- **STATE:** GA
- **ZIP:** 30099

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM** 8-K

**CURRENT REPORT** 

PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (Date of earliest event reported): February 23, 2023

![img185879976_0.jpg](img185879976_0.jpg)

Primerica, Inc.

(Exact Name of Registrant as Specified in Its Charter)

---

| | | | |
|:---|:---|:---|:---|
| <br>Delaware | <br>Delaware | <br>001-34680 | <br>27-1204330 |
| (State or other jurisdiction of<br>incorporation) | (State or other jurisdiction of<br>incorporation) | (Commission File Number) | (IRS Employer<br>Identification No.) |
|  |  | <br>1 Primerica Parkway<br>Duluth, Georgia 30099 |  |
|  | (Address of Principal Executive Offices, and Zip Code) | (Address of Principal Executive Offices, and Zip Code) | (Address of Principal Executive Offices, and Zip Code) |

---

(770) 381-1000

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Title of each class | &nbsp;&nbsp;Trading Symbol(s) | &nbsp;&nbsp;Name of each exchange on which registered |
| &nbsp;&nbsp;Common Stock | &nbsp;&nbsp;PRI | &nbsp;&nbsp;New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

On February 23, 2023, Primerica, Inc. (the "Company") announced its results of operations for the quarter ended December 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1.

The information provided pursuant to this Item 2.02, including Exhibit 99.1 in Item 9.01, is "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, and shall not be incorporated by reference in any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended (the "Securities Act"), except to the extent expressly set forth by specific reference in any such filings.

**Use of Non-GAAP Financial Measures** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to reporting financial results in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company presents certain non-GAAP financial measures. Specifically, the Company presents adjusted direct premiums, other ceded premiums, adjusted operating revenues, adjusted operating income before income taxes, adjusted net operating income, adjusted stockholders' equity and diluted adjusted operating earnings per share. Adjusted direct premiums and other ceded premiums are net of amounts ceded under coinsurance transactions that were executed concurrent with our initial public offering (the "IPO coinsurance transactions") for all periods presented. We exclude amounts ceded under the IPO coinsurance transactions in measuring adjusted direct premiums and other ceded premiums to present meaningful comparisons of the actual premiums economically maintained by the Company. Amounts ceded under the IPO coinsurance transactions will continue to decline over time as policies terminate within this block of business. Adjusted operating revenues, adjusted operating income before income taxes, adjusted net operating income and diluted adjusted operating earnings per share exclude the impact of investment gains (losses) and fair value mark-to-market ("MTM") investment adjustments, including credit impairments, for all periods presented. We exclude investment gains (losses), including credit impairments, and MTM investment adjustments in measuring these non-GAAP financial measures to eliminate period-over-period fluctuations that may obscure comparisons of operating results due to items such as the timing of recognizing gains (losses) and market pricing variations prior to an invested asset's maturity or sale that are not directly associated with the Company's insurance operations. Adjusted operating income before taxes, adjusted net operating income, and diluted adjusted operating earnings per share also exclude the loss on the extinguishment of debt, transaction-related expenses/recoveries associated with the purchase of e-TeleQuote Insurance, Inc. and subsidiaries (collectively, "e-TeleQuote"), adjustments to share-based compensation expense for shares exchanged in the business combination, and non-cash goodwill impairment charges. We exclude the loss on the extinguishment of debt, e-TeleQuote transaction-related expenses/recoveries and non-cash goodwill impairment charges as these are non-recurring items that will cause incomparability between period-over-period results. We exclude adjustments to share-based compensation expense for shares exchanged in the business combination to eliminate period-over-period fluctuations that may obscure comparisons of operating results primarily due to the volatility of changes in the fair value of shares which were acquired for no additional consideration. Adjusted operating income before income taxes and adjusted net operating income exclude income attributable to the noncontrolling interest to present only the income that is attributable to stockholders of the Company. Adjusted stockholders' equity excludes the impact of net unrealized investment gains (losses) recorded in accumulated other comprehensive income (loss) for all periods presented. We exclude unrealized investment gains (losses) in measuring adjusted stockholders' equity as unrealized gains (losses) from the Company's available-for-sale securities are largely caused by market movements in interest rates and credit spreads that do not necessarily correlate with the cash flows we will ultimately realize when an available-for-sale security matures or is sold.

Our definitions of these non-GAAP financial measures may differ from the definitions of similar measures used by other companies. Management uses these non-GAAP financial measures in making financial,

------

operating and planning decisions and in evaluating the Company's performance. Furthermore, management believes that these non-GAAP financial measures may provide users with additional meaningful comparisons between current results and results of prior periods as they are expected to be reflective of our core ongoing business. These measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of the Company's results as reported under GAAP.

Reconciliations of GAAP to non-GAAP financial measures are included as attachments to the press release which has been posted in the "Investor Relations" section of our website at https://investors.primerica.com.

**Item 7.01 Regulation FD Disclosure.**

On February 23, 2023, the Company posted to the "Investor Relations" section of its website certain supplemental financial information relating to the quarter ended December 31, 2023. A copy of the supplemental financial information is attached hereto as Exhibit 99.2.

The information provided pursuant to this Item 7.01, including Exhibit 99.2 in Item 9.01, is "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of such section, and shall not be incorporated by reference in any filing made by the Company under the Exchange Act or the Securities Act, except to the extent expressly set forth by specific reference in any such filings.

---

| | |
|:---|:---|
| <br>**Item 9.01.** | <br>**Financial Statements and Exhibits.** |
| **(d) Exhibits.** |  |
| 99.1 | [<u>Press Release dated February 23, 2023 – Primerica Reports Fourth Quarter 2022 Results</u>](pri-ex99_1.htm)<br>|
| 99.2 | [<u>Primerica, Inc. Supplemental Financial Information – Fourth Quarter 2022</u>](pri-ex99_2.htm)<br>|
| 104 | Cover Page from this Current Report on Form 8-K, formatted in Inline XBRL |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| Date: February 23, 2023 | **PRIMERICA, INC.** |
|  | /s/ Alison S. Rand |
|  | Alison S. Rand |
|  | Executive Vice President and Chief Financial Officer |

---

------

## Ex-99

**Exhibit 99.1**

![img164271198_0.jpg](img164271198_0.jpg)

**PRIMERICA REPORTS FOURTH QUARTER 2022 RESULTS** 

**Life-licensed sales force grew 4.4% to a record 135,208 representatives**

**Term Life net premiums increased 5%; adjusted direct premiums increased 6%**

**Investment and Savings Products sales reached $10 billion for full year 2022; second largest in Company history despite equity market volatility**

**Executed a successful senior health Medicare annual enrollment period**

**Net earnings per diluted share (EPS) of $3.54; return on stockholders' equity (ROE) 31.6%**

**Diluted adjusted operating EPS of $3.49, up 19%; adjusted net operating income return on adjusted stockholders' equity (ROAE) of 27.1%**

**Duluth, GA, February 23, 2023 –** Primerica, Inc. (NYSE: PRI) today announced financial results for the quarter ended December 31, 2022. GAAP revenues were $686.9 million, down 5% from the prior year period. Net income was $131.8 million, earnings per diluted share was $3.54 and ROE was 31.6% for the quarter. Net income, earnings per diluted share and ROE comparisons to the prior year results are not meaningful due to a goodwill impairment charge recognized in the fourth quarter of 2021.

Adjusted net operating revenues of $684.5 million decreased 5% compared to the prior year's fourth quarter. Adjusted net operating income was $129.9 million, up 11% while diluted adjusted operating earnings per share of $3.49 increased 19% year-over-year. ROAE was 27.1% for the quarter. The Company adjusts operating results to exclude non-recurring items that cause incomparability between periods. A reconciliation of non-GAAP to GAAP financial measures is included at the end of this release.

"Our success in 2022 reflects the value of guidance that our sales force brings to middle-income families and the important role they play in encouraging clients to take action," said Glenn Williams, Chief Executive Officer. "For three consecutive years, Primerica has issued more than $100 billion in term life insurance face amount. And while inflation and market volatility created headwinds, our representatives successfully helped their clients invest $10 billion in 2022 toward their future financial goals."

------

Term Life operating results during the fourth quarter reflected a significant reduction in COVID-related death claims year-over-year and continued normalization of policy persistency. Claims were favorable to historical trends in the fourth quarter and rising interest rates positively impacted benefit reserves when the Company locked in its assumptions for new business during the period as further described below. Economic uncertainty continued to pressure equity markets, which adversely impacted sales and client asset values in the Investment and Savings Products ("ISP") segment. Senior health results improved year-over-year as the Company continued to navigate the evolving marketplace.

Comparing results for the year ended December 31, 2022 to the year ended December 31, 2021, income before income taxes of $493.7 million declined 3%, while adjusted operating income before income taxes of $567.0 million declined 6%. Term Life pre-tax operating income grew 8% year-over-year, in line with 8% growth in adjusted direct premiums as the impact of the pandemic on the life insurance business faded. ISP pre-tax operating income declined 13% year-over-year driven by the impact of equity market volatility on product sales and client asset values. Higher losses in the Senior Health segment, lower mortgage sales due to rising interest rates and the cost of holding an additional sales force leadership event in 2022 also contributed to the year-over-year decline in operating income.

**Fourth Quarter Distribution & Segment Results**

---

| | | | |
|:---|:---|:---|:---|
| **Distribution Results** | **Distribution Results** | **Distribution Results** | **Distribution Results** |
|  | **Q4 2022** | **Q4 2021** | **% Change** |
| &nbsp;&nbsp;Life-Licensed Sales Force | 135208 | 129515 | 4% |
| &nbsp;&nbsp;Recruits | 77025 | 73572 | 5% |
| &nbsp;&nbsp;New Life-Licensed Representatives | 11117 | 9296 | 20% |
| &nbsp;&nbsp;Life Insurance Policies Issued | 72544 | 75203 | (4)% |
| &nbsp;&nbsp;Life Productivity (1) | 0.18 | 0.19 | \* |
| &nbsp;&nbsp;ISP Product Sales ($ billions) | $2.09 | $3.02 | (31)% |
| &nbsp;&nbsp;Average Client Asset Values ($ billions) | $83.26 | $94.81 | (12)% |
| &nbsp;&nbsp;Senior Health Submitted Policies (2) | 23060 | 39142 | (41)% |
| &nbsp;&nbsp;Senior Health Approved Policies (3) | 20705 | 32047 | (35)% |
| &nbsp;&nbsp;Closed U.S. Mortgage Volume ($ million brokered) | $78.9 | $330.8 | (76)% |

---

------

<sup>(1)</sup> Life productivity equals policies issued divided by the average number of life insurance licensed representatives per month

<sup>(2)</sup> Represents the number of completed applications that, with respect to each such application, the applicant has authorized us to submit to the health insurance carrier

<sup>(3)</sup> Represents an estimate of submitted policies approved by health insurance carriers during the indicated period. Not all approved policies will go in force

\* Not calculated

------

---

| | | | |
|:---|:---|:---|:---|
| **Segment Results** | **Segment Results** | **Segment Results** | **Segment Results** |
|  | **Q4 2022** | **Q4 2021** | **% Change** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| **Adjusted Operating Revenues:** |  |  |  |
| &nbsp;&nbsp;Term Life Insurance | $430160 | $408672 | 5% |
| &nbsp;&nbsp;Investment and Savings Products | 198280 | 247076 | (20)% |
| &nbsp;&nbsp;Senior Health **(1)** | 27853 | 37504 | (26)% |
| &nbsp;&nbsp;Corporate and Other Distributed Products **(1)** | 28210 | 29746 | (5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjusted operating revenues **(1)** | $684503 | $722998 | (5)% |
| **Adjusted Operating Income (Loss) before <br> income taxes:** |  |  |  |
| &nbsp;&nbsp;Term Life Insurance | $125321 | $102019 | 23% |
| &nbsp;&nbsp;Investment and Savings Products | 57417 | 70699 | (19)% |
| &nbsp;&nbsp;Senior Health **(1)** | 4285 | 369 | NM |
| &nbsp;&nbsp;Corporate and Other Distributed Products **(1)** | (21913) | (22345) | (2)% |
| &nbsp;&nbsp;Total adjusted operating income before <br> income taxes **(1)** | $165110 | $150742 | 10% |

---

------

<sup>(1)</sup> See the Non-GAAP Financial Measures section and the Adjusted Operating Results reconciliation tables at the end of this release for additional information.

**Life Insurance Licensed Sales Force**

The Company continued to capitalize on the attractiveness and flexibility of its entrepreneurial business opportunity, ending 2022 with a record 135,208 independent life-licensed representatives, a 4.4% increase compared to December 31, 2021. Growth in the sales force was supported by strong recruiting over the last 12 months, including 77,025 individuals who joined Primerica during the fourth quarter of 2022. Licensing momentum continued with 11,117 new life-licensed representatives during the fourth quarter of 2022, a 20% increase compared to the prior year period.

**Term Life Insurance** 

The Company issued 72,544 new term life insurance policies during the fourth quarter, decreasing 4% compared to the prior year period, while issued term life face amount was nearly flat year-over-year. The year-over-year decline in sales volume was due to a slow start in October as the sales force anticipated and prepared for the Company's introduction of new life insurance products. Following a successful product launch, momentum started to build again in November and December. We also believe an increased cost-of-living impacted sales to some degree. Productivity remained in its historical range at 0.18 policies per life-licensed representative per month versus 0.19 in the prior year period.

Fourth quarter revenues of $430.2 million increased 5% year-over-year, driven by 6% growth in adjusted direct premiums, while pre-tax income of $125.3 million increased 23% due primarily to a reduction in benefits and claims. The benefits and claims ratio, which is typically lower in the fourth quarter due to seasonally weaker persistency, was 56.6%. The ratio reflects claims that were $3 million favorable to historical trends in the current period compared to excess claims of $19 million driven largely by COVID in the prior year period. In addition, the Company's annual process to lock in new business assumptions under current GAAP, which historically takes place during the fourth quarter, resulted in

------

a reserve reduction of $4 million primarily due to higher interest rates. Finally, the administrative reprocessing of certain reinsurance transactions lowered benefits and claims by $2 million.

Persistency has largely normalized in the aggregate, however, lapse rates remained elevated for policies written at the height of the pandemic, while lapses for policies issued prior to the pandemic were generally lower. The DAC amortization ratio of 16.6% for the quarter reflects seasonally weaker persistency and is largely in line with fourth quarter ratios prior to the pandemic. The fourth quarter operating margin was 21.5% compared to 18.6% in the prior year period.

**Investment and Savings Products** 

Total ISP sales during the quarter were $2.1 billion, or 31% lower than the prior year period. Heightened market volatility and economic uncertainty continued to impact investor confidence, pressuring sales and client asset values. However, the Company recorded net inflows of $649 million during the quarter with redemption levels remaining just below 2% of the beginning of quarter assets, which continues to reflect clients' commitment to their long-term investment objectives. Client asset values ended the year at $83.9 billion, down 14% compared to December 31, 2021.

Revenues of $198.3 million declined 20% and pre-tax income of $57.4 million declined 19% year-over-year due to 35% lower sales-based revenue generating sales and 12% lower average client asset values. Sales-based and asset-based commission revenues and expenses generally declined in line with their related drivers.

**Senior Health**

Results reflected seasonally heightened activity associated with the Medicare annual enrollment period ("AEP") with nearly 21,000 policies approved during the fourth quarter. As intended, the Company approved fewer policies than the approximately 32,000 approved in the prior year period as it continues to evaluate emerging profitability dynamics in the sector. The lifetime value of commissions per approved policy ("LTV") was $888 and the contract acquisition costs per approved policy ("CAC") was $722, for an LTV/CAC ratio of 1.2x for the period.

Revenues of $27.9 million declined year-over-year as a result of a lower number of approved policies. The Company recognized a positive revenue adjustment of $3.8 million this quarter, largely to reflect the final first year commission collections on 2022 effective policies that was higher than assumed throughout the year. The adjustment increased first year commission revenues to match the actual cash received during the year since these commissions are no longer subject to chargeback. The Company made progress in efficiently procuring and utilizing leads as reflected in a 21% year-over-year improvement of CAC. Adjusted operating income before taxes was $4.3 million in the fourth quarter of 2022 versus adjusted operating income attributable to Primerica of $0.4 million in the prior year period. The Company did not need to provide any funding to the Senior Health segment during the quarter.

------

**Corporate and Other Distributed Products**

During the fourth quarter, the segment recorded an adjusted operating loss before income taxes of $21.9 million compared to a $22.3 million loss in the prior year period. The segment had strong growth in allocated net investment income as described further on a consolidated basis below. Higher market interest rates continued to adversely impact mortgage loan volume. Insurance and other operating expenses increased as a result of general corporate expenditures, including employee compensation and investments in technology. Additionally, interest expense was lower year-over-year, reflecting an overlap of interest obligation during the issuance of new senior notes in 2021.

**Invested Asset Portfolio**

Consolidated net investment income increased $8.5 million compared to the prior year period, reflecting higher yields on new investments and growth in the size of the invested asset portfolio. About half of the increase was allocated to the Term Life segment as the in-force business continues to grow with the remainder recorded in Corporate and Other Distributed Products.

The invested asset portfolio ended the quarter with an unrealized loss of $306 million, compared to an unrealized loss of $321 million at September 30, 2022 reflecting relatively unchanged Treasury rates, but tighter credit spreads during the period. The Company does not believe the unrealized loss is due to significant credit concerns but is instead due to increasing interest rates and intends to hold these investments until maturity.

**Taxes** 

The effective tax rate during the fourth quarter was 21.3% compared to 47.9% in the fourth quarter of 2021. The 2021 period included a goodwill impairment charge for which the Company does not receive a tax benefit. Excluding the goodwill impairment charge, the effective tax rate in the fourth quarter of 2021 was 22.3%. The effective tax rate in the fourth quarter of 2022 includes a current period tax benefit from revaluing the Canadian deferred tax asset to reflect an incremental Canadian federal tax enacted in December. The incremental Canadian tax is imposed on taxable income in excess of $100 million for banks and life insurance companies.

**Capital** 

During the quarter, the Company repurchased $32.0 million of common stock, for a total of $356.3 million in 2022, resulting in completion of its prior authorization. As announced in November 2022, the Company received a new authorization for a $375 million share repurchase program in 2023. The Board of Directors has also approved a dividend of $0.65 per share, payable on March 14, 2023, to stockholders of record on February 21, 2023.

The Company has a strong balance sheet, including invested assets and cash at the holding company of $307 million. Primerica Life Insurance Company's statutory risk-based capital (RBC) ratio was estimated to be about 475% as of December 31, 2022.

------

**Non-GAAP Financial Measures** 

In addition to reporting financial results in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company presents certain non-GAAP financial measures. Specifically, the Company presents adjusted direct premiums, other ceded premiums, adjusted operating revenues, adjusted operating income before income taxes, adjusted net operating income, adjusted stockholders' equity and diluted adjusted operating earnings per share. Adjusted direct premiums and other ceded premiums are net of amounts ceded under coinsurance transactions that were executed concurrent with our initial public offering (the "IPO coinsurance transactions") for all periods presented. We exclude amounts ceded under the IPO coinsurance transactions in measuring adjusted direct premiums and other ceded premiums to present meaningful comparisons of the actual premiums economically maintained by the Company. Amounts ceded under the IPO coinsurance transactions will continue to decline over time as policies terminate within this block of business. Adjusted operating revenues, adjusted operating income before income taxes, adjusted net operating income and diluted adjusted operating earnings per share exclude the impact of investment gains (losses) and fair value mark-to-market ("MTM") investment adjustments, including credit impairments, for all periods presented. We exclude investment gains (losses), including credit impairments, and MTM investment adjustments in measuring these non-GAAP financial measures to eliminate period-over-period fluctuations that may obscure comparisons of operating results due to items such as the timing of recognizing gains (losses) and market pricing variations prior to an invested asset's maturity or sale that are not directly associated with the Company's insurance operations. Adjusted operating income before taxes, adjusted net operating income, and diluted adjusted operating earnings per share also exclude the loss on the extinguishment of debt, transaction-related expenses/recoveries associated with the purchase of e-TeleQuote Insurance, Inc. and subsidiaries (collectively, "e-TeleQuote"), adjustments to share-based compensation expense for shares exchanged in the business combination, and non-cash goodwill impairment charges. We exclude the loss on the extinguishment of debt, e-TeleQuote transaction-related expenses/recoveries and non-cash goodwill impairment charges as these are non-recurring items that will cause incomparability between period-over-period results. We exclude adjustments to share-based compensation expense for shares exchanged in the business combination to eliminate period-over-period fluctuations that may obscure comparisons of operating results primarily due to the volatility of changes in the fair value of shares which were acquired for no additional consideration. Adjusted operating income before income taxes and adjusted net operating income exclude income attributable to the noncontrolling interest to present only the income that is attributable to stockholders of the Company. Adjusted stockholders' equity excludes the impact of net unrealized investment gains (losses) recorded in accumulated other comprehensive income (loss) for all periods presented. We exclude unrealized investment gains (losses) in measuring adjusted stockholders' equity as unrealized gains (losses) from the Company's available-for-sale securities are largely caused by market movements in interest rates and credit spreads that do not necessarily correlate with the cash flows we will ultimately realize when an available-for-sale security matures or is sold.

------

Our definitions of these non-GAAP financial measures may differ from the definitions of similar measures used by other companies. Management uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating the Company's performance. Furthermore, management believes that these non-GAAP financial measures may provide users with additional meaningful comparisons between current results and results of prior periods as they are expected to be reflective of the core ongoing business. These measures have limitations and investors should not consider them in isolation or as a substitute for analysis of the Company's results as reported under GAAP. Reconciliations of GAAP to non-GAAP financial measures are attached to this release.

**Earnings Webcast Information**

Primerica will hold a webcast on Friday, February 24, 2023 at 10:00 a.m. Eastern, to discuss the quarter's results. To access the webcast, go to https://investors.primerica.com at least 15 minutes prior to the event to register, download and install any necessary software. A replay of the call will be available for approximately 30 days. This release and a detailed financial supplement will be posted on Primerica's website.

**Forward-Looking Statements** 

Except for historical information contained in this press release, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements contain known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from anticipated or projected results. Those risks and uncertainties include, among others, our failure to continue to attract and license new recruits, retain sales representatives or license or maintain the licensing of sales representatives; new laws or regulations that could apply to our distribution model, which could require us to modify our distribution structure; changes to the independent contractor status of sales representatives; our or sales representatives' violation of or non-compliance with laws and regulations; any failure to protect the confidentiality of client information; differences between our actual experience and our expectations regarding mortality or persistency as reflected in the pricing for our insurance policies; changes in federal, state and provincial legislation or regulation that affects our insurance, investment product and mortgage businesses; our failure to meet regulatory capital ratios or other minimum capital and surplus requirements; a significant downgrade by a ratings organization; the failure of our reinsurers or reserve financing counterparties to perform their obligations; the failure of our investment products to remain competitive with other investment options or the loss of our relationship with one or more of the companies whose investment products we provide; litigation and regulatory investigations and actions concerning us or sales representatives; heightened standards of conduct or more stringent licensing requirements for sales representatives; inadequate policies and procedures regarding suitability review of client transactions; revocation of our subsidiary's status as a non-bank custodian; economic down cycles that impact our

------

business, financial condition and results of operations; major public health pandemics, epidemics or outbreaks or other catastrophic events; the failure of our information technology systems, breach of our information security, failure of our business continuity plan or the loss of the Internet; the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio and other assets; incorrectly valuing our investments; changes in accounting standards may impact how we record and report our financial condition and results of operations; the inability of our subsidiaries to pay dividends or make distributions; litigation and regulatory investigations and actions; a significant change in the competitive environment in which we operate; the loss of key personnel or sales force leaders; any acquisition or investment in businesses that do not perform as we expect or are difficult to integrate; due to our very limited history with e-TeleQuote, we cannot be certain that its business will be successful or that we will successfully address any risks not known to us that may become material; a failure by e-TeleQuote to comply with the requirements of the United States government's Centers for Medicare and Medicaid Services and those of its carrier partners; legislative or regulatory changes to Medicare Advantage or changes to the implementing guidance by the Centers for Medicare and Medicaid Services; e-TeleQuote's inability to acquire or generate leads on commercially viable terms, convert leads to sales or if customer policy retention is lower than assumed; e-TeleQuote's inability to enroll individuals during the Medicare annual election period; the loss of a key carrier, or the modification of commission rates or underwriting practices with a key carrier partner could adversely affect e-TeleQuote's business; cyber-attack(s), security breaches or if e-TeleQuote is otherwise unable to safeguard the security and privacy of confidential data, including personal health information; and fluctuations in the market price of our common stock or Canadian currency exchange rates. These and other risks and uncertainties affecting us are more fully described in our filings with the Securities and Exchange Commission, which are available in the "Investor Relations" section of our website at https://investors.primerica.com. Primerica assumes no duty to update its forward-looking statements as of any future date.

**About Primerica, Inc.** 

Primerica, Inc., headquartered in Duluth, GA, is a leading provider of financial services to middle-income households in North America. Independent licensed representatives educate Primerica clients about how to better prepare for a more secure financial future by assessing their needs and providing appropriate solutions through term life insurance, which we underwrite, and mutual funds, annuities and other financial products, which we distribute primarily on behalf of third parties. We insured over 5.7 million lives and had over 2.7 million client investment accounts on December 31, 2021. Primerica, through its insurance company subsidiaries, was the #2 issuer of Term Life insurance coverage in the United States and Canada in 2021. Primerica stock is included in the S&P MidCap 400 and the Russell 1000 stock indices and is traded on The New York Stock Exchange under the symbol "PRI".

**Investor Contact:**

Nicole Russell

------

470-564-6663<br>Email: Nicole.Russell@primerica.com

**Media Contact:**

Susan Chana

404-229-8302

Email: Susan.Chana@Primerica.com

------

---

| | | |
|:---|:---|:---|
| **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** |
| **Condensed Consolidated Balance Sheets** | **Condensed Consolidated Balance Sheets** | **Condensed Consolidated Balance Sheets** |
|  | **(Unaudited)** |  |
|  | **December 31, 2022** | **December 31, 2021** |
|  | **(In thousands)** | **(In thousands)** |
| **Assets** |  |  |
| &nbsp;&nbsp;Investments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed-maturity securities available-for-sale, at fair value | $2495456 | $2702567 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed-maturity security held-to-maturity, at amortized cost | 1444920 | 1379100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments available-for-sale, at fair value | 69406 | 85243 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities, at fair value | 35404 | 42551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trading securities, at fair value | 3698 | 24355 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy loans and other invested assets | 48713 | 30612 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investments | 4097597 | 4264428 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 489240 | 392501 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued investment income | 20885 | 18702 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance recoverables | 4015909 | 4268419 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred policy acquisition costs, net | 3081886 | 2943782 |
| &nbsp;&nbsp;&nbsp;&nbsp;Renewal commissions receivable | 200043 | 231751 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agent balances, due premiums and other receivables | 254276 | 257675 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 127707 | 179154 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets | 185525 | 195825 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes | 101333 | 81799 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 40500 | 47942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 428259 | 441253 |
| &nbsp;&nbsp;&nbsp;&nbsp;Separate account assets | 2305717 | 2799992 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $15348877 | $16123223 |
| **Liabilities and Stockholders' Equity** |  |  |
| &nbsp;&nbsp;Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Future policy benefits | $7390800 | $7138649 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unearned and advance premiums | 15422 | 16437 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy claims and other benefits payable | 538250 | 585382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other policyholders' funds | 483769 | 501823 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable - short term | - | 15000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable - long term | 592905 | 592102 |
| &nbsp;&nbsp;&nbsp;&nbsp;Surplus note | 1444469 | 1378585 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes | 128333 | 241311 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 45995 | 53920 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 580780 | 615710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable under securities lending | 100938 | 94529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Separate account liabilities | 2305717 | 2799992 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 13627378 | 14033440 |
| **Temporary Stockholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redeemable noncontrolling interests in consolidated entities | - | 7271 |
| **Permanent Stockholders' equity** |  |  |
| &nbsp;&nbsp;Equity attributable to Primerica, Inc.: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 368 | 394 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | - | 5224 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1973403 | 2004506 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss), net of income tax | (252272) | 72388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total permanent stockholders' equity | 1721499 | 2082512 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and temporary and permanent stockholders' equity | $15348877 | $16123223 |

---

------

---

| | | |
|:---|:---|:---|
| **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** |
| **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **Three months ended December 31,** | **Three months ended December 31,** |
|  | **2022** | **2021** |
|  | **(In thousands, except per-share amounts)** | **(In thousands, except per-share amounts)** |
| **Revenues:** |  |  |
| &nbsp;&nbsp;Direct premiums | $812481 | $794344 |
| &nbsp;&nbsp;Ceded premiums | (406088) | (405147) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net premiums | 406393 | 389197 |
| &nbsp;&nbsp;Commissions and fees | 226720 | 288285 |
| &nbsp;&nbsp;Net investment income | 28530 | 20001 |
| &nbsp;&nbsp;Investment gains (losses) | 2845 | 1995 |
| &nbsp;&nbsp;Other, net | 22451 | 24616 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 686939 | 724094 |
| **Benefits and expenses:** |  |  |
| &nbsp;&nbsp;Benefits and claims | 154130 | 187192 |
| &nbsp;&nbsp;Amortization of deferred policy acquisition costs | 93776 | 68575 |
| &nbsp;&nbsp;Sales commissions | 103162 | 139842 |
| &nbsp;&nbsp;Insurance expenses | 58883 | 53359 |
| &nbsp;&nbsp;Insurance commissions | 7280 | 8542 |
| &nbsp;&nbsp;Contract acquisition costs | 14952 | 29264 |
| &nbsp;&nbsp;Interest expense | 6768 | 8804 |
| &nbsp;&nbsp;Goodwill impairment loss | - | 76000 |
| &nbsp;&nbsp;Loss on extinguishment of debt | - | 8927 |
| &nbsp;&nbsp;Other operating expenses | 80442 | 77291 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total benefits and expenses | 519393 | 657796 |
| &nbsp;&nbsp;Income before income taxes | 167546 | 66298 |
| &nbsp;&nbsp;Income taxes | 35706 | 31788 |
| &nbsp;&nbsp;Net income | $131840 | $34510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | - | (360) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to Primerica, Inc. | $131840 | $34870 |
| **Earnings per share attributable to common stockholders:** |  |  |
| &nbsp;&nbsp;Basic earnings per share | $3.55 | $0.88 |
| &nbsp;&nbsp;Diluted earnings per share | $3.54 | $0.87 |
| **Weighted-average shares used in computing <br> earnings per share:** |  |  |
| &nbsp;&nbsp;Basic | 36974 | 39568 |
| &nbsp;&nbsp;Diluted | 37081 | 39691 |

---

------

---

| | | |
|:---|:---|:---|
| **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** |
| **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
|  | **Year ended December 31,** | **Year ended December 31,** |
|  | **2022** | **2021** |
|  | **(In thousands, except per-share amounts)** | **(In thousands, except per-share amounts)** |
| **Revenues:** |  |  |
| &nbsp;&nbsp;Direct premiums | $3230120 | $3122148 |
| &nbsp;&nbsp;Ceded premiums | (1629892) | (1616264) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net premiums | 1600228 | 1505884 |
| &nbsp;&nbsp;Commissions and fees | 944676 | 1042813 |
| &nbsp;&nbsp;Net investment income | 93065 | 80588 |
| &nbsp;&nbsp;Investment gains (losses) | (995) | 5872 |
| &nbsp;&nbsp;Other, net | 83159 | 74575 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 2720133 | 2709732 |
| **Benefits and expenses:** |  |  |
| &nbsp;&nbsp;Benefits and claims | 665749 | 722753 |
| &nbsp;&nbsp;Amortization of deferred policy acquisition costs | 356143 | 251179 |
| &nbsp;&nbsp;Sales commissions | 462764 | 522308 |
| &nbsp;&nbsp;Insurance expenses | 235405 | 202605 |
| &nbsp;&nbsp;Insurance commissions | 30261 | 34532 |
| &nbsp;&nbsp;Contract acquisition costs | 68431 | 52788 |
| &nbsp;&nbsp;Interest expense | 27237 | 30618 |
| &nbsp;&nbsp;Goodwill impairment loss | 60000 | 76000 |
| &nbsp;&nbsp;Loss on extinguishment of debt | - | 8927 |
| &nbsp;&nbsp;Other operating expenses | 320394 | 296851 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total benefits and expenses | 2226384 | 2198561 |
| &nbsp;&nbsp;Income before income taxes | 493749 | 511171 |
| &nbsp;&nbsp;Income taxes | 125775 | 139191 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $367974 | $371980 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to noncontrolling interests | (5038) | (1377) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to Primerica, Inc. | $373012 | $373357 |
| **Earnings per share attributable to common stockholders:** |  |  |
| &nbsp;&nbsp;Basic earnings per share | $9.77 | $9.41 |
| &nbsp;&nbsp;Diluted earnings per share | $9.74 | $9.38 |
| **Weighted-average shares used in computing <br> earnings per share:** |  |  |
| &nbsp;&nbsp;Basic | 37997 | 39530 |
| &nbsp;&nbsp;Diluted | 38106 | 39652 |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** |
| **Consolidated Adjusted Operating Results Reconciliation** | **Consolidated Adjusted Operating Results Reconciliation** | **Consolidated Adjusted Operating Results Reconciliation** | **Consolidated Adjusted Operating Results Reconciliation** |
| **(Unaudited – in thousands, except per share amounts)** | **(Unaudited – in thousands, except per share amounts)** | **(Unaudited – in thousands, except per share amounts)** | **(Unaudited – in thousands, except per share amounts)** |
|  | **Three months ended December 31,** | **Three months ended December 31,** |  |
|  | **2022** | **2021** | **% Change** |
| Total revenues | $686939 | $724094 | (5)% |
| Less: Investment gains (losses) | 2845 | 1995 |  |
| Less: 10% deposit asset MTM included in NII | (409) | (899) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating revenues | $684503 | $722998 | (5)% |
| Income before income taxes | $167546 | $66298 | 153% |
| Less: Investment gains (losses) | 2845 | 1995 |  |
| Less: 10% deposit asset MTM included in NII | (409) | (899) |  |
| Less: e-TeleQuote transaction-related expenses | - | (812) |  |
| Less: Equity comp for awards exchanged during acquisition | - | 739 |  |
| Less: Noncontrolling interest | - | (540) |  |
| Less: Goodwill impairment | - | (76000) |  |
| Less: Loss on extinguishment of debt | - | (8927) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes | $165110 | $150742 | 10% |
| Net income | $131840 | $34510 | 282% |
| Less: Investment gains (losses) | 2845 | 1995 |  |
| Less: 10% deposit asset MTM included in NII | (409) | (899) |  |
| Less: e-TeleQuote transaction-related expenses | - | (812) |  |
| Less: Equity comp for awards exchanged during acquisition | - | 739 |  |
| Less: Noncontrolling interest | - | (540) |  |
| Less: Goodwill impairment | - | (76000) |  |
| Less: Loss on extinguishment of debt | - | (8927) |  |
| Less: Tax impact of preceding items | (520) | 1945 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net operating income | $129924 | $117009 | 11% |
| Diluted earnings per share (1) | $3.54 | $0.87 | 307% |
| Less: Net after-tax impact of operating adjustments | 0.05 | (2.07) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted adjusted operating earnings per share (1) | $3.49 | $2.94 | 19% |

---

------

<sup>(1)</sup> Percentage change in earnings per share is calculated prior to rounding per share amounts.

------

---

| | | | |
|:---|:---|:---|:---|
| **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** |
| **Consolidated Adjusted Operating Results Reconciliation** | **Consolidated Adjusted Operating Results Reconciliation** | **Consolidated Adjusted Operating Results Reconciliation** | **Consolidated Adjusted Operating Results Reconciliation** |
| **(Unaudited – in thousands, except per share amounts)** | **(Unaudited – in thousands, except per share amounts)** | **(Unaudited – in thousands, except per share amounts)** | **(Unaudited – in thousands, except per share amounts)** |
|  | **Year ended December 31,** | **Year ended December 31,** |  |
|  | **2022** | **2021** | **% Change** |
| Total revenues | $2720133 | $2709732 | 0% |
| Less: Investment gains (losses) | (995) | 5872 |  |
| Less: 10% deposit asset MTM included in NII | (3830) | (2502) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating revenues | $2724958 | $2706362 | 1% |
| Income before income taxes | $493749 | $511171 | (3)% |
| Less: Investment gains (losses) | (995) | 5872 |  |
| Less: 10% deposit asset MTM included in NII | (3830) | (2502) |  |
| Less: e-TeleQuote transaction-related expenses | 1992 | (12948) |  |
| Less: Equity comp for awards exchanged during acquisition | (3584) | 1744 |  |
| Less: Noncontrolling interest | (6797) | (2005) |  |
| Less: Goodwill impairment | (60000) | (76000) |  |
| Less: Loss on extinguishment of debt | - | (8927) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes | $566963 | $605937 | (6)% |
| Net income | $367974 | $371980 | (1)% |
| Less: Investment gains (losses) | (995) | 5872 |  |
| Less: 10% deposit asset MTM included in NII | (3830) | (2502) |  |
| Less: e-TeleQuote transaction-related expenses | 1992 | (12948) |  |
| Less: Equity comp for awards exchanged during acquisition | (3584) | 1744 |  |
| Less: Noncontrolling interest | (6797) | (2005) |  |
| Less: Goodwill impairment | (60000) | (76000) |  |
| Less: Loss on extinguishment of debt | - | (8927) |  |
| Less: Tax impact of preceding items | 3303 | 4548 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net operating income | $437885 | $462197 | (5)% |
| Diluted earnings per share (1) | $9.74 | $9.38 | 4% |
| Less: Net after-tax impact of operating adjustments | (1.69) | (2.23) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted adjusted operating earnings per share (1) | $11.44 | $11.61 | (1)% |

---

------

<sup>(1)</sup> Percentage change in earnings per share is calculated prior to rounding per share amounts.

---

| | | | |
|:---|:---|:---|:---|
| **TERM LIFE INSURANCE SEGMENT** | **TERM LIFE INSURANCE SEGMENT** | **TERM LIFE INSURANCE SEGMENT** | **TERM LIFE INSURANCE SEGMENT** |
| **Adjusted Premiums Reconciliation** | **Adjusted Premiums Reconciliation** | **Adjusted Premiums Reconciliation** | **Adjusted Premiums Reconciliation** |
| **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** |
|  | **Three months ended December 31,** | **Three months ended December 31,** |  |
|  | **2022** | **2021** | **% Change** |
| Direct premiums | $807796 | $789325 | 2% |
| Less: Premiums ceded to IPO coinsurers | 224240 | 239828 |  |
| &nbsp;&nbsp;Adjusted direct premiums | 583556 | 549497 | 6% |
| Ceded premiums | (404174) | (403184) |  |
| Less: Premiums ceded to IPO coinsurers | (224240) | (239828) |  |
| &nbsp;&nbsp;Other ceded premiums | (179934) | (163356) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net premiums | $403622 | $386141 | 5% |

---

------

---

| | | |
|:---|:---|:---|
| **SENIOR HEALTH SEGMENT** | **SENIOR HEALTH SEGMENT** | **SENIOR HEALTH SEGMENT** |
| **Adjusted Operating Results Reconciliation** | **Adjusted Operating Results Reconciliation** | **Adjusted Operating Results Reconciliation** |
| **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** |
|  | **Three months ended December 31,** | **Three months ended December 31,** |
|  | **2022** | **2021**<br> **% Change** |
| Income/(loss) before income taxes | $4285 | $(76560) NM |
| Less: e-TeleQuote transaction-related costs | - | (389) |
| Less: Noncontrolling interest | - | (540) |
| Less: Goodwill impairment | - | (76000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before taxes | $4285 | $369<br> NM |

---

---

| | | | |
|:---|:---|:---|:---|
| **CORPORATE AND OTHER DISTRIBUTED PRODUCTS SEGMENT** | **CORPORATE AND OTHER DISTRIBUTED PRODUCTS SEGMENT** | **CORPORATE AND OTHER DISTRIBUTED PRODUCTS SEGMENT** | **CORPORATE AND OTHER DISTRIBUTED PRODUCTS SEGMENT** |
| **Adjusted Operating Results Reconciliation** | **Adjusted Operating Results Reconciliation** | **Adjusted Operating Results Reconciliation** | **Adjusted Operating Results Reconciliation** |
| **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** |
|  | **Three months ended December 31,** | **Three months ended December 31,** |  |
|  | **2022** | **2021** | **% Change** |
| Total revenues | $30646 | $30842 | (1)% |
| Less: Investment gains (losses) | 2845 | 1995 |  |
| Less: 10% deposit asset MTM included in NII | (409) | (899) |  |
| &nbsp;&nbsp;Adjusted operating revenues | $28210 | $29746 | (5)% |
| Loss before income taxes | $(19477) | $(29860) | (35)% |
| Less: Investment gains (losses) | 2845 | 1995 |  |
| Less: 10% deposit asset MTM included in NII | (409) | (899) |  |
| Less: e-TeleQuote transaction-related expenses | - | (423) |  |
| Less: Equity comp for awards exchanged during acquisition | - | 739 |  |
| Less: Loss on extinguishment of debt | - | (8927) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating loss before income taxes | $(21913) | $(22345) | (2)% |

---

---

| | | | |
|:---|:---|:---|:---|
| **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** | **PRIMERICA, INC. AND SUBSIDIARIES** |
| **Adjusted Stockholders' Equity Reconciliation** | **Adjusted Stockholders' Equity Reconciliation** | **Adjusted Stockholders' Equity Reconciliation** | **Adjusted Stockholders' Equity Reconciliation** |
| **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** | **(Unaudited – in thousands)** |
|  | **December 31, 2022** | **December 31, 2021** | **% Change** |
| Stockholders' equity (1) | $1721499 | $2082512 | (17)% |
| Less: Unrealized net investment gains (losses) recorded <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in stockholders' equity, net of income tax | (240869) | 63777 |  |
| &nbsp;&nbsp;Adjusted stockholders' equity (1) | $1962368 | $2018735 | (3)% |

---

------

<sup>(1)</sup> Reflects the Company's permanent stockholders' equity and does not include temporary stockholders' equity.

------

## Ex-99

**Exhibit 99.2**

![img165194719_0.jpg](img165194719_0.jpg)

Supplemental Financial Information

Fourth Quarter 2022

------

---

| | |
|:---|:---|
| **Table of Contents** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | |
|:---|:---|
|  | <u>Page</u> |
| Preface, definition of Non-GAAP financial measures | 3 |
| Condensed balance sheets and reconciliation of balance sheet non-GAAP to GAAP financial measures | 4 |
| Financial results and other statistical data  | 5 |
| Statements of income  | 6 |
| Reconciliation of statement of income GAAP to non-GAAP financial measures | 7-8 |
| Segment operating results  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Life Insurance segment - financial results, key statistics, and financial analysis  | 9-10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment and Savings Products segment - financial results, financial analysis, and key statistics  | 11-12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Health segment - financial results, financial analysis, and key statistics | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate & Other Distributed Products segment - financial results | 14 |
| Investment portfolio  | 15-17 |
| Five-year historical key statistics  | 18 |

---

------

This document may contain forward-looking statements and information. Additional information and factors that could cause actual results to differ materially from any forward-looking statements or information in this document is available in our Form 10-K for the year ended December 31, 2021.

2 of 18

------

---

| | |
|:---|:---|
| **Preface** | **PRIMERICA, INC.**<br>Financial Supplement |

---

**<u>Fourth Quarter 2022</u>**

This document is a financial supplement to our fourth quarter 2022 earnings release. It is designed to enable comprehensive analysis of our ongoing business using the same core metrics that our management utilizes in assessing our business and making strategic and operational decisions. Throughout this document we provide financial information that is derived from our U.S. GAAP financial statements and adjusted for three different purposes, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Operating</u> adjustments exclude the impact of investment gains/losses, including credit impairments, mark-to-market (MTM) investment adjustments, loss on the extinguishment of debt, transaction-related expenses/recoveries associated with the purchase of e-TeleQuote Insurance, Inc. and subsidiaries (collectively, "e-TeleQuote"), adjustments to share-based compensation expense for shares exchanged in the business combination, and non-cash goodwill impairment charges. We exclude investment gains/losses, including credit impairments, and MTM investment adjustments in measuring adjusted operating revenues to eliminate period-over-period fluctuations that may obscure comparisons of operating results due to items such as the timing of recognizing gains and losses and other factors prior to an invested asset's maturity or sale that are not directly associated the Company's insurance operations. We exclude the loss on the extinguishment of debt, e-TeleQuote transaction-related expenses/recoveries, and non-cash goodwill impairment charges in our non-GAAP financial measures as such expenses are non-recurring items that will cause incomparability between period-over-period results. We exclude adjustments to share-based compensation expense for shares exchanged in the business combination to eliminate period-over-period fluctuations that may obscure comparisons of operating results primarily due to the volatility of changes in the fair value of shares which were acquired for no additional consideration. Adjusted operating income before income taxes and adjusted net operating income exclude income attributable to the noncontrolling interest to present only the income that is attributable to stockholders of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>Adjusted stockholders' equity</u> refers to the removal of the impact of net unrealized gains and losses on invested assets. We exclude unrealized investment gains and losses in measuring adjusted stockholders' equity as unrealized gains and losses from the Company's invested assets are largely caused by market movements in interest rates and credit spreads that do not necessarily correlate with the cash flows we will ultimately realize when an invested asset matures or is sold.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<u>IPO coinsurance transactions</u> adjustments relate to transactions in the first quarter of 2010, where we coinsured between 80% and 90% of our business that was in-force at year-end 2009 to entities then affiliated with Citigroup Inc. that were executed concurrent with our initial public offering (IPO). We exclude amounts ceded under the IPO coinsurance transactions in measuring adjusted direct premiums and other ceded premiums to present meaningful comparisons of the actual premiums economically maintained by the Company. Amounts ceded under the IPO coinsurance transactions will continue to decline over time as policies terminate within this block of business.

Management utilizes these non-GAAP financial measures in managing the business and believes they present relevant and meaningful analytical metrics for evaluating the ongoing business. Reconciliations of non-GAAP to GAAP financial measures are included in this financial supplement.

Certain items throughout this supplement may not add due to rounding and as such, may not agree to other public reporting of the respective item. Certain items throughout this supplement are noted as 'na' to indicate not applicable. Certain variances are noted as 'nm' to indicate not meaningful. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on net income or total stockholders' equity.

3 of 18

------

---

| | |
|:---|:---|
| **Condensed Balance Sheets and Reconciliation of Balance Sheet Non-GAAP to GAAP Financial Measures** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| (Dollars in thousands) | **Dec 31,<br>2020** | **Mar 31,<br>2021** | **Jun 30,<br>2021** | **Sep 30,<br>2021** | **Dec 31,<br>2021** | **Mar 31,<br>2022** | **Jun 30,<br>2022** | **Sep 30,<br>2022** | **Dec 31,<br>2022** |
| **Condensed Balance Sheets** |  |  |  |  |  |  |  |  |  |
| **Assets:** |  |  |  |  |  |  |  |  |  |
| Investments and cash excluding securities held to maturity | $3096703 | $3133860 | $3431825 | $3056395 | $3277830 | $3191154 | $3048974 | $2981598 | $3141919 |
| Securities held to maturity | 1346350 | 1362210 | 1368740 | 1376090 | 1379100 | 1390310 | 1415940 | 1433760 | 1444920 |
| Total investments and cash | 4443053 | 4496070 | 4800565 | 4432485 | 4656930 | 4581464 | 4464914 | 4415358 | 4586839 |
| Due from reinsurers | 4273904 | 4345483 | 4239510 | 4278322 | 4268419 | 4240481 | 4069039 | 4033897 | 4015909 |
| Deferred policy acquisition costs | 2629644 | 2712169 | 2808347 | 2877921 | 2943782 | 2994367 | 3028511 | 3049102 | 3081886 |
| Goodwill |  |  |  | 224180 | 179154 | 179154 | 187707 | 127707 | 127707 |
| Other assets | 899165 | 921236 | 925621 | 1330620 | 1274946 | 1242457 | 1219847 | 1209471 | 1230820 |
| Separate account assets | 2659520 | 2638901 | 2745827 | 2672606 | 2799992 | 2696891 | 2358987 | 2206608 | 2305717 |
| Total assets | $14905286 | $15113858 | $15519871 | $15816135 | $16123222 | $15934813 | $15329005 | $15042143 | $15348877 |
| **Liabilities:** |  |  |  |  |  |  |  |  |  |
| Future policy benefits | $6790557 | $6885115 | $6984272 | $7057599 | $7138649 | $7216597 | $7276278 | $7314688 | $7390800 |
| Other policy liabilities | 984612 | 1020349 | 977373 | 1054925 | 1103642 | 1108047 | 999789 | 1005195 | 1037440 |
| Income taxes | 223496 | 235233 | 204197 | 260264 | 241311 | 217326 | 164971 | 129347 | 128333 |
| Other liabilities | 618874 | 633719 | 641025 | 668643 | 669631 | 683865 | 646660 | 659582 | 626776 |
| Debt obligations | 374415 | 374511 | 499606 | 514702 | 607102 | 598303 | 592504 | 592705 | 592905 |
| Surplus note | 1345772 | 1361648 | 1368194 | 1375559 | 1378585 | 1389811 | 1415457 | 1433293 | 1444469 |
| Payable under securities lending | 72154 | 87190 | 80613 | 105264 | 94529 | 93171 | 96603 | 80754 | 100938 |
| Separate account liabilities | 2659520 | 2638901 | 2745827 | 2672606 | 2799992 | 2696891 | 2358987 | 2206608 | 2305717 |
| Total liabilities | 13069401 | 13236666 | 13501107 | 13709563 | 14033442 | 14004011 | 13551249 | 13422171 | 13627379 |
| **Redeemable noncontrolling interest** | $— | $— | $— | $7631 | $7271 | $4616 | $2233 | $— | $— |
| **Stockholders' equity:** |  |  |  |  |  |  |  |  |  |
| Common stock ($0.01 par value) (1) | 393 | 394 | 394 | 395 | 394 | 388 | 378 | 370 | 368 |
| Paid-in capital | (0) | 8138 | 12880 | 17454 | 5224 | (0) | (0) | (0) | (0) |
| Retained earnings | 1705786 | 1785037 | 1894539 | 1988324 | 2004506 | 1980467 | 1948244 | 1887952 | 1973403 |
| Treasury stock |  |  |  |  |  |  |  |  |  |
| Accumulated other comprehensive income (loss), net: |  |  |  |  |  |  |  |  |  |
| Net unrealized gains (losses) | 128128 | 77053 | 96990 | 84701 | 63775 | (66439) | (175746) | (252913) | (240869) |
| Cumulative translation adjustment | 1578 | 6570 | 13960 | 8068 | 8611 | 11769 | 2648 | (15437) | (11404) |
| Total stockholders' equity (2) | 1835885 | 1877192 | 2018764 | 2098941 | 2082510 | 1926185 | 1775524 | 1619971 | 1721498 |
| Total liabilities and stockholders' equity | $14905286 | $15113858 | $15519871 | $15816135 | $16123222 | $15934813 | $15329005 | $15042143 | $15348877 |
| **Reconciliation of Total Stockholders' Equity to Adjusted Stockholders' Equity** |  |  |  |  |  |  |  |  |  |
| Total stockholders' equity | $1835885 | $1877192 | $2018764 | $2098941 | $2082510 | $1926185 | $1775524 | $1619971 | $1721498 |
| Less: Net unrealized gains (losses) | 128128 | 77053 | 96990 | 84701 | 63775 | (66439) | (175746) | (252913) | (240869) |
| Adjusted stockholders' equity | $1707757 | $1800139 | $1921774 | $2014241 | $2018735 | $1992624 | $1951270 | $1872885 | $1962368 |
| **Adjusted Stockholders' Equity Rollforward** |  |  |  |  |  |  |  |  |  |
| Balance, beginning of period | $1614688 | $1707757 | $1800139 | $1921774 | $2014241 | $2018735 | $1992624 | $1951270 | $1872885 |
| Net Income attributable to Primerica, Inc. | 100084 | 97872 | 128162 | 112456 | 34868 | 81418 | 107947 | 51807 | 131840 |
| Shareholder dividends | (15851) | (18620) | (18660) | (18671) | (18686) | (21645) | (21178) | (20571) | (20389) |
| Retirement of shares and warrants | (13426) | (5966) | (521) | (88) | (18829) | (103862) | (127963) | (97515) | (32098) |
| Net foreign currency translation adjustment | 16398 | 4992 | 7390 | (5892) | 543 | 3158 | (9121) | (18086) | 4034 |
| Other, net | 5864 | 14105 | 5264 | 4662 | 6597 | 14820 | 8961 | 5979 | 6096 |
| Balance, end of period | $1707757 | $1800139 | $1921774 | $2014241 | $2018735 | $1992624 | $1951270 | $1872885 | $1962368 |
| **Deferred Policy Acquisition Costs Rollforward** |  |  |  |  |  |  |  |  |  |
| Balance, beginning of period | $2532409 | $2629644 | $2712169 | $2808347 | $2877921 | $2943782 | $2994367 | $3028511 | $3049102 |
| General expenses deferred | 9510 | 10558 | 10055 | 9248 | 9062 | 9519 | 9321 | 9726 | 9283 |
| Commission costs deferred | 128084 | 134188 | 136085 | 129287 | 124515 | 123739 | 119794 | 119734 | 113479 |
| Amortization of deferred policy acquisition costs | (53342) | (66105) | (54286) | (62214) | (68575) | (86063) | (85379) | (90925) | (93776) |
| Foreign currency impact and other, net | 12984 | 3884 | 4324 | (6748) | 858 | 3390 | (9593) | (17943) | 3797 |
| Balance, end of period | $2629644 | $2712169 | $2808347 | $2877921 | $2943782 | $2994367 | $3028511 | $3049102 | $3081886 |

---

------

(1) Outstanding common shares exclude restricted stock units.

(2) Reflects the company's permanent stockholders' equity and does not include temporary stockholders' equity.

4 of 18

------

---

| | |
|:---|:---|
| **Financial Results and Other Statistical Data** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands, except per-share data) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$/#<br>Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$/#<br>Change** | **%<br>Change** |
| **Earnings per Share** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Basic earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Weighted-average common shares and fully vested equity awards | 39455948 | 39530691 | 39560786 | 39568470 | 39221003 | 38385520 | 37438254 | 36973967 | (2594503 | -6.6% | 39529786 | 37996978 | (1532808 | -3.9% |
| Net income attributable to Primerica, Inc. | $97872 | $128162 | $112456 | $34868 | $81418 | $107947 | $51807 | $131840 | $96972 | nm | $373357 | $373012 | $(345 | -0.1% |
| Less income attributable to unvested participating securities | (417 | (525 | (458 | (141 | (337 | (477 | (244 | (632 | (491 | nm | (1533 | (1684 | (151 | -9.8% |
| Net income used in computing basic EPS | $97455 | $127636 | $111997 | $34728 | $81081 | $107470 | $51563 | $131209 | $96481 | nm | $371824 | $371329 | $(495 | -0.1% |
| Basic earnings per share | $2.47 | $3.23 | $2.83 | $0.88 | $2.07 | $2.80 | $1.38 | $3.55 | $2.67 | nm | $9.41 | $9.77 | $0.37 | 3.9% |
| Adjusted net operating income | $97129 | $129355 | $118708 | $117007 | $83333 | $110701 | $113928 | $129924 | $12917 | 11.0% | $462199 | $437886 | $(24313 | -5.3% |
| Less operating income attributable to unvested participating securities | (414 | (530 | (484 | (472 | (345 | (490 | (537 | (622 | (150 | -31.9% | (1898 | (1977 | (79 | -4.1% |
| Adjusted net operating income used in computing basic operating EPS | $96715 | $128825 | $118224 | $116535 | $82988 | $110212 | $113391 | $129302 | $12767 | 11.0% | $460301 | $435909 | $(24392 | -5.3% |
| Basic adjusted operating income per share | $2.45 | $3.26 | $2.99 | $2.95 | $2.12 | $2.87 | $3.03 | $3.50 | $0.55 | 18.7% | $11.64 | $11.47 | $(0.17 | -1.5% |
| Diluted earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Weighted-average common shares and fully vested equity awards | 39455948 | 39530691 | 39560786 | 39568470 | 39221003 | 38385520 | 37438254 | 36973967 | (2594503 | -6.6% | 39529786 | 37996978 | (1532808 | -3.9% |
| Dilutive impact of contingently issuable shares | 124505 | 121595 | 117923 | 122929 | 110941 | 115058 | 102810 | 107245 | (15684 | -12.8% | 121738 | 109014 | (12724 | -10.5% |
| Shares used to calculate diluted EPS | 39580453 | 39652286 | 39678709 | 39691399 | 39331944 | 38500578 | 37541064 | 37081212 | (2610187 | -6.6% | 39651524 | 38105992 | (1545532 | -3.9% |
| Net income attributable to Primerica, Inc. | $97872 | $128162 | $112456 | $34868 | $81418 | $107947 | $51807 | $131840 | $96972 | nm | $373357 | $373012 | $(345 | -0.1% |
| Less income attributable to unvested participating securities | (416 | (524 | (457 | (140 | (337 | (476 | (244 | (630 | (490 | nm | (1529 | (1680 | (151 | -9.9% |
| Net income used in computing diluted EPS | $97456 | $127638 | $111998 | $34728 | $81081 | $107471 | $51563 | $131210 | $96482 | nm | $371828 | $371332 | $(495 | -0.1% |
| Diluted earnings per share | $2.46 | $3.22 | $2.82 | $0.87 | $2.06 | $2.79 | $1.37 | $3.54 | $2.66 | nm | $9.38 | $9.74 | $0.37 | 3.9% |
| Adjusted net operating income | $97129 | $129355 | $118708 | $117007 | $83333 | $110701 | $113928 | $129924 | $12917 | 11.0% | $462199 | $437886 | $(24313 | -5.3% |
| Less operating income attributable to unvested participating securities | (413 | (529 | (483 | (471 | (344 | (488 | (536 | (621 | (150 | -31.9% | (1893 | (1972 | (79 | -4.2% |
| Adjusted net operating income used in computing diluted operating EPS | $96717 | $128827 | $118225 | $116536 | $82988 | $110213 | $113392 | $129303 | $12767 | 11.0% | $460306 | $435914 | $(24393 | -5.3% |
| Diluted adjusted operating income per share | $2.44 | $3.25 | $2.98 | $2.94 | $2.11 | $2.86 | $3.02 | $3.49 | $0.55 | 18.8% | $11.61 | $11.44 | $(0.17 | -1.5% |
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
|  | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$/#<br>Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$/#<br>Change** | **%<br>Change** |
| **Annualized Return on Equity** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Average stockholders' equity (1) | $1856539 | $1947978 | $2058852 | $2090726 | $2004348 | $1850855 | $1697748 | $1670735 | $(419991 | -20.1% | $1988524 | $1805921 | $(182603 | -9.2% |
| Average adjusted stockholders' equity (1) | $1753948 | $1860956 | $1968007 | $2016488 | $2005679 | $1971947 | $1912077 | $1917626 | $(98862 | -4.9% | $1899850 | $1951832 | $51983 | 2.7% |
| Net income attributable to Primerica, Inc. return on stockholders' equity | 21.1 | 26.3 | 21.8 | 6.7 | 16.2 | 23.3 | 12.2 | 31.6 | 24.9 | nm | 18.8 | 20.7 | 1.9 | nm |
| Net income attributable to Primerica, Inc. return on adjusted stockholders' equity | 22.3 | 27.5 | 22.9 | 6.9 | 16.2 | 21.9 | 10.8 | 27.5 | 20.6 | nm | 19.7 | 19.1 | -0.5 | nm |
| Adjusted net operating income return on adjusted stockholders' equity | 22.2 | 27.8 | 24.1 | 23.2 | 16.6 | 22.5 | 23.8 | 27.1 | 3.9 | nm | 24.3 | 22.4 | -1.9 | nm |
| **Capital Structure** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Debt-to-capital (2) | 16.6 | 19.8 | 19.7 | 22.6 | 23.7 | 25.0 | 26.8 | 25.6 | 3.0 | nm | 22.6 | 25.6 | 3.0 | nm |
| Debt-to-capital, excluding AOCI (2) | 17.3 | 20.8 | 20.4 | 23.2 | 23.2 | 23.3 | 23.9 | 23.1 | -0.1 | nm | 23.2 | 23.1 | -0.1 | nm |
| Cash and invested assets to stockholders' equity | 2.4 | 2.4 | 2.1 | 2.2 | 2.4 | 2.5 | 2.7 | 2.7 | 0.4 | nm | 2.2 | 2.7 | 0.4 | nm |
| Cash and invested assets to adjusted stockholders' equity | 2.5 | 2.5 | 2.2 | 2.3 | 2.3 | 2.3 | 2.4 | 2.3 | 0.0 | nm | 2.3 | 2.3 | 0.0 | nm |
| Share count, end of period (3) | 39414085 | 39443561 | 39470748 | 39367754 | 38751885 | 37768052 | 37026600 | 36824428 | (2543326 | -6.5% | 39367754 | 36824428 | (2543326 | -6.5% |
| Adjusted stockholders' equity per share | $45.67 | $48.72 | $51.03 | $51.28 | $51.42 | $51.66 | $50.58 | $53.29 | $2.01 | 3.9% | $51.28 | $53.29 | $2.01 | 3.9% |
| **Financial Strength Ratings - Primerica Life Insurance Co** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Moody's | A1 | A1 | A1 | A1 | A1 | A1 | A1 | A1 | nm | nm | nm | nm | nm | nm |
| S&P | AA- | AA- | AA- | AA- | AA- | AA- | AA- | AA- | nm | nm | nm | nm | nm | nm |
| A.M. Best | A+ | A+ | A+ | A+ | A+ | A+ | A+ | A+ | nm | nm | nm | nm | nm | nm |
| **Holding Company Senior Debt Ratings** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Moody's | Baa1 | Baa1 | Baa1 | Baa1 | Baa1 | Baa1 | Baa1 | Baa1 | nm | nm | nm | nm | nm | nm |
| S&P | A- | A- | A- | A- | A- | A- | A- | A- | nm | nm | nm | nm | nm | nm |
| A.M. Best | a- | a- | a- | a- | a- | a- | a- | a- | nm | nm | nm | nm | nm | nm |

---

------

(1) Reflects the company's permanent stockholders' equity and does not include temporary stockholders' equity.

(2) Debt-to-capital is that of the parent company only. Capital in the debt-to-capital ratio includes stockholders' equity and the note payable.

(3) Share count reflects outstanding common shares, but excludes restricted stock units (RSUs).

5 of 18

------

---

| | |
|:---|:---|
| **Statements of Income** | <br>**PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Statement of Income** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| **Revenues:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Direct premiums | $762227 | $780299 | $785277 | $794344 | $798666 | $808894 | $810079 | $812481 | $18136 | 2.3% | $3122148 | $3230120 | $107972 | 3.5% |
| Ceded premiums | (395973) | (413850) | (401295) | (405147) | (399885) | (419048) | (404870) | (406088) | (941) | -0.2% | (1616264) | (1629892) | (13627) | -0.8% |
| Net premiums | 366254 | 366450 | 383983 | 389197 | 398781 | 389846 | 405209 | 406393 | 17196 | 4.4% | 1505884 | 1600229 | 94344 | 6.3% |
| Net investment income | 20052 | 20535 | 20000 | 20001 | 18905 | 21284 | 24346 | 28530 | 8530 | 42.6% | 80588 | 93065 | 12477 | 15.5% |
| Commissions and fees: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Sales-based (1) | 98112 | 104716 | 95229 | 103451 | 103242 | 88701 | 67962 | 66473 | (36978) | -35.7% | 401508 | 326378 | (75130) | -18.7% |
| Asset-based (2) | 101241 | 108490 | 113558 | 118015 | 113112 | 108101 | 107483 | 105357 | (12657) | -10.7% | 441303 | 434053 | (7250) | -1.6% |
| Account-based (3) | 21120 | 21848 | 21456 | 22514 | 21541 | 22592 | 22910 | 23348 | 834 | 3.7% | 86939 | 90391 | 3453 | 4.0% |
| Other commissions and fees | 13571 | 15635 | 39553 | 44304 | 13905 | 21294 | 27113 | 31542 | (12763) | -28.8% | 113063 | 93854 | (19209) | -17.0% |
| Investment (losses) gains | 1766 | 701 | 1410 | 1995 | 751 | (1892) | (2699) | 2846 | 850 | 42.6% | 5872 | (995) | (6867) | -116.9% |
| Other, net | 15595 | 16313 | 18051 | 24616 | 20988 | 18755 | 20964 | 22451 | (2165) | -8.8% | 74575 | 83159 | 8584 | 11.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total revenues | 637711 | 654687 | 693240 | 724094 | 691225 | 668681 | 673288 | 686940 | (37154) | -5.1% | 2709732 | 2720134 | 10402 | 0.4% |
| **Benefits and expenses:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Benefits and claims | 183789 | 168347 | 183425 | 187192 | 187069 | 153257 | 171293 | 154130 | (33062) | -17.7% | 722753 | 665748 | (57004) | -7.9% |
| Amortization of DAC | 66105 | 54286 | 62214 | 68575 | 86063 | 85379 | 90925 | 93776 | 25201 | 36.7% | 251179 | 356143 | 104964 | 41.8% |
| Insurance commissions | 8740 | 8838 | 8412 | 8542 | 7721 | 7594 | 7666 | 7280 | (1262) | -14.8% | 34532 | 30261 | (4271) | -12.4% |
| Insurance expenses | 48766 | 48579 | 51901 | 53359 | 59509 | 59461 | 57552 | 58883 | 5525 | 10.4% | 202604 | 235405 | 32801 | 16.2% |
| Sales commissions: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Sales-based (1) | 68594 | 73629 | 67745 | 77390 | 74606 | 63403 | 48775 | 47927 | (29463) | -38.1% | 287359 | 234711 | (52648) | -18.3% |
| Asset-based (2) | 46866 | 50488 | 53233 | 55614 | 53366 | 50876 | 51549 | 51047 | (4567) | -8.2% | 206201 | 206838 | 637 | 0.3% |
| Other sales commissions | 6434 | 7185 | 8290 | 6839 | 5952 | 5484 | 5592 | 4187 | (2652) | -38.8% | 28748 | 21215 | (7533) | -26.2% |
| Interest expense | 7145 | 7141 | 7529 | 8804 | 6853 | 6814 | 6802 | 6768 | (2035) | -23.1% | 30618 | 27237 | (3381) | -11.0% |
| Contract acquistion costs (4) |  |  | 23524 | 29264 | 20649 | 19384 | 13446 | 14952 | (14312) | -48.9% | 52788 | 68431 | 15643 | 29.6% |
| Other operating expenses | 72964 | 66730 | 79866 | 77292 | 86434 | 79728 | 73790 | 80443 | 3151 | 4.1% | 296851 | 320394 | 23544 | 7.9% |
| Goodwill impairment |  |  |  | 76000 |  |  | 60000 |  | (76000) | -100.0% | 76000 | 60000 | (16000) | -21.1% |
| Loss on extinguishment of debt |  |  |  | 8927 |  |  |  |  | (8927) | -100.0% | 8927 |  | (8927) | -100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total benefits and expenses | 509403 | 485222 | 546138 | 657797 | 588222 | 531381 | 587389 | 519393 | (138404) | -21.0% | 2198561 | 2226385 | 27824 | 1.3% |
| Income before income taxes | 128308 | 169465 | 147102 | 66296 | 103003 | 137300 | 85899 | 167547 | 101250 | nm | 511171 | 493749 | (17422) | -3.4% |
| Income taxes | 30437 | 41304 | 35663 | 31788 | 24239 | 31737 | 34092 | 35706 | 3918 | 12.3% | 139191 | 125775 | (13417) | -9.6% |
| Net income | 97872 | 128162 | 111439 | 34508 | 78764 | 105563 | 51807 | 131840 | 97333 | nm | 371980 | 367974 | (4006) | -1.1% |
| Net income attributable to noncontrolling interests |  |  | (1017) | (360) | (2654) | (2384) |  |  | 360 | 100.0% | (1377) | (5038) | (3661) | nm |
| Net Income attributable to Primerica, Inc. | $97872 | $128162 | $112456 | $34868 | $81418 | $107947 | $51807 | $131840 | $96972 | nm | $373357 | $373012 | $(345) | -0.1% |
| **Income Before Income Taxes by Segment** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Term Life | $88236 | $116778 | $107589 | $102019 | $91577 | $119878 | $111763 | $125321 | $23302 | 22.8% | $414621 | $448540 | $33918 | 8.2% |
| Investment & Savings Products | 63363 | 71154 | 69369 | 70699 | 64560 | 58975 | 58377 | 57417 | (13282) | -18.8% | 274585 | 239329 | (35255) | -12.8% |
| Senior Health |  |  | (8489) | (76561) | (23085) | (16150) | (63723) | 4285 | 80846 | 105.6% | (85050) | (98673) | (13624) | -16.0% |
| Corporate & Other Distributed Products | (23290) | (18467) | (21367) | (29861) | (30048) | (25403) | (20518) | (19477) | 10384 | 34.8% | (92985) | (95446) | (2461) | -2.6% |
| Income before income taxes | $128308 | $169465 | $147102 | $66296 | $103003 | $137300 | $85899 | $167547 | $101250 | nm | $511171 | $493749 | $(17422) | -3.4% |

---

------

(1) <u>Sales-based</u> - revenues or commission expenses relating to the sales of mutual funds and variable annuities.

(2) <u>Asset-based</u> - revenues or commission expenses relating to the value of assets in client accounts for which we earn ongoing service, distribution, and other fees.

(3) <u>Account-based</u> - revenues relating to the fee generating client accounts we administer.

(4) <u>Contract acquisition costs (CAC)</u> - Includes direct marketing costs incurred to acquire Senior Health product leads through internal and external sources, including commissions paid to Primerica representatives, as well as ETQ agent compensation, training and licensing costs.

6 of 18

------

---

| | |
|:---|:---|
| **Reconciliation of Statement of Income GAAP to Non-GAAP Financial Measures** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Reconciliation from Term Life Direct Premiums to Term Life Adjusted Direct Premiums** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Term Life direct premiums | $756514 | $774500 | $779490 | $789325 | $793254 | $803453 | $804586 | $807796 | $18471 | 2.3% | $3099828 | $3209088 | $109260 | 3.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Premiums ceded to IPO Coinsurers | 249944 | 246874 | 241439 | 239828 | 234614 | 231805 | 226869 | 224240 | (15589) | -6.5% | 978085 | 917527 | (60558) | -6.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term Life adjusted direct premiums | $506570 | $527626 | $538051 | $549496 | $558640 | $571648 | $577717 | $583556 | $34060 | 6.2% | $2121743 | $2291561 | $169818 | 8.0% |
| **Reconciliation from Term Life Ceded Premiums to Term Life Other Ceded Premiums** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Term Life ceded premiums | $(394550) | $(412028) | $(399835) | $(403184) | $(398446) | $(417406) | $(403416) | $(404174) | $(990) | -0.2% | $(1609598) | $(1623442) | $(13845) | -0.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Premiums ceded to IPO Coinsurers | (249944) | (246874) | (241439) | (239828) | (234614) | (231805) | (226869) | (224240) | 15589 | 6.5% | (978085) | (917527) | 60558 | 6.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term Life other ceded premiums | $(144606) | $(165154) | $(158397) | $(163356) | $(163832) | $(185601) | $(176548) | $(179935) | $(16578) | -10.1% | $(631513) | $(705915) | $(74403) | -11.8% |
| **Reconciliation from Net Investment Income to Adjusted Net Investment Income** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Net Investment Income | $20052 | $20535 | $20000 | $20001 | $18905 | $21284 | $24346 | $28530 | $8530 | 42.6% | $80588 | $93065 | $12477 | 15.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: MTM investment adjustments | (793) | (170) | (640) | (899) | (2099) | (1254) | (68) | (409) | nm | nm | (2502) | (3830) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net investment income | $20845 | $20705 | $20640 | $20900 | $21004 | $22538 | $24414 | $28940 | $8040 | 38.5% | $83091 | $96896 | $13805 | 16.6% |
| **Reconciliation from Other Operating Expenses to Adjusted other operating expenses** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Other operating expenses | $72964 | $66730 | $79866 | $77292 | $86434 | $79728 | $73790 | $80443 | $3151 | 4.1% | $296851 | $320394 | $23544 | 7.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: eTeleQuote transaction-related costs |  | 2109 | 10027 | 812 | 900 | (2892) |  |  | nm | nm | 12948 | (1992) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Equity comp for awards exchanged during acquisition |  |  | (1004) | (739) | 256 | 3328 |  |  | nm | nm | (1744) | 3584 | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted other operating expenses | $72964 | $64620 | $70843 | $77219 | $85278 | $79292 | $73790 | $80443 | $3224 | 4.2% | $285646 | $318803 | $33156 | 11.6% |
| **Reconciliation from Total Revenues to Adjusted Operating Revenues** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Total revenues | $637711 | $654687 | $693240 | $724094 | $691225 | $668681 | $673288 | $686940 | $(37154) | -5.1% | $2709732 | $2720134 | $10402 | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Investment gains/(losses) | 1766 | 701 | 1410 | 1995 | 751 | (1892) | (2699) | 2846 | nm | nm | 5872 | (995) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: MTM investment adjustments | (793) | (170) | (640) | (899) | (2099) | (1254) | (68) | (409) | nm | nm | (2502) | (3830) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating revenues | $636738 | $654156 | $692470 | $722998 | $692573 | $671827 | $676056 | $684503 | $(38494) | -5.3% | $2706363 | $2724960 | $18597 | 0.7% |
| **Reconciliation from Income Before Income Taxes to Adjusted Operating Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Income before income taxes | $128308 | $169465 | $147102 | $66296 | $103003 | $137300 | $85899 | $167547 | $101250 | nm | $511171 | $493749 | $(17422) | -3.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Investment gains/(losses) | 1766 | 701 | 1410 | 1995 | 751 | (1892) | (2699) | 2846 | nm | nm | 5872 | (995) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: MTM investment adjustments | (793) | (170) | (640) | (899) | (2099) | (1254) | (68) | (409) | nm | nm | (2502) | (3830) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: eTeleQuote transaction-related costs |  | (2109) | (10027) | (812) | (900) | 2892 |  |  | nm | nm | (12948) | 1992 | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Equity comp for awards exchanged during acquisition |  |  | 1004 | 739 | (256) | (3328) |  |  | nm | nm | 1744 | (3584) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Noncontrolling interest before income taxes |  |  | (1465) | (540) | (3668) | (3129) |  |  | nm | nm | (2005) | (6797) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Goodwill impairment |  |  |  | (76000) |  |  | (60000) |  | nm | nm | (76000) | (60000) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Loss on extinguishment of debt |  |  |  | (8927) |  |  |  |  | nm | nm | (8927) |  | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes | $127335 | $171044 | $156819 | $150740 | $109175 | $144011 | $148667 | $165110 | $14370 | 9.5% | $605938 | $566963 | $(38975) | -6.4% |
| **Reconciliation from Net Income to Adjusted Net Operating Income** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Net income | $97872 | $128162 | $111439 | $34508 | $78764 | $105563 | $51807 | $131840 | $97333 | nm | $371980 | $367974 | $(4006) | -1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Investment gains/(losses) | 1766 | 701 | 1410 | 1995 | 751 | (1892) | (2699) | 2846 | nm | nm | 5872 | (995) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: MTM investment adjustments | (793) | (170) | (640) | (899) | (2099) | (1254) | (68) | (409) | nm | nm | (2502) | (3830) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: e-TeleQuote transaction-related costs |  | (2109) | (10027) | (812) | (900) | 2892 |  |  | nm | nm | (12948) | 1992 | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Equity comp for awards exchanged during acquisition |  |  | 1004 | 739 | (256) | (3328) |  |  | nm | nm | 1744 | (3584) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Noncontrolling interest before income taxes |  |  | (1465) | (540) | (3668) | (3129) |  |  | nm | nm | (2005) | (6797) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Goodwill impairment |  |  |  | (76000) |  |  | (60000) |  | nm | nm | (76000) | (60000) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Loss on extinguishment of debt |  |  |  | (8927) |  |  |  |  | nm | nm | (8927) |  | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Tax impact of reconciling items | (231) | 385 | 2449 | 1945 | 1603 | 1573 | 647 | (520) | nm | nm | 4548 | 3303 | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net operating income | $97129 | $129355 | $118708 | $117007 | $83333 | $110701 | $113928 | $129924 | $12917 | 11.0% | $462199 | $437886 | $(24313) | -5.3% |

---

------

7 of 18

------

---

| | |
|:---|:---|
| **Reconciliation of Statement of Income GAAP to Non-GAAP Financial Measures** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Reconciliation from Senior Health Income Before Income Taxes to Senior Health Adjusted Operating Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Income before income taxes | na | na | $(8489) | $(76561) | $(23085) | $(16150) | $(63723) | $4285 | $80846 | 105.6% | $(85050) | $(98673) | $(13624) | -16.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: e-TeleQuote transaction-related costs | na | na | (417) | (389) | (399) | (66) |  |  | nm | nm | (806) | (465) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Noncontrolling interest | na | na | (1465) | (540) | (3668) | (3129) |  |  | nm | nm | (2005) | (6797) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Goodwill impairment | na | na |  | (76000) |  |  | (60000) |  | nm | nm | (76000) | (60000) | nm | nm |
| Adjusted operating income before income taxes | na | na | $(6608) | $369 | $(19018) | $(12955) | $(3723) | $4285 | $3917 | nm | $(6239) | $(31411) | $(25172) | nm |
| **Reconciliation from C&O Income Before Income Taxes to C&O Adjusted Operating Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Income before income taxes | $(23290) | $(18467) | $(21367) | $(29861) | $(30048) | $(25403) | $(20518) | $(19477) | $10384 | 34.8% | $(92985) | $(95446) | $(2461) | -2.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Investment gains/(losses) | 1766 | 701 | 1410 | 1995 | 751 | (1892) | (2699) | 2846 | nm | nm | 5872 | (995) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: MTM investment adjustments | (793) | (170) | (640) | (899) | (2099) | (1254) | (68) | (409) | nm | nm | (2502) | (3830) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: e-TeleQuote transaction-related costs |  | (2109) | (9610) | (423) | (501) | 2958 |  |  | nm | nm | (12142) | 2458 | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Equity comp for awards exchanged during acquistion |  |  | 1004 | 739 | (256) | (3328) |  |  | nm | nm | 1744 | (3584) | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Loss on extinguishment of debt |  |  |  | (8927) |  |  |  |  | nm | nm | (8927) |  | nm | nm |
| Adjusted operating income before income taxes | $(24263) | $(16888) | $(13531) | $(22346) | $(27943) | $(21887) | $(17750) | $(21914) | $432 | 1.9% | $(77029) | $(89495) | $(12466) | -16.2% |

---

8 of 18

------

---

| | |
|:---|:---|
| **Term Life Insurance - Financial Results and Analysis** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Term Life Insurance Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| **Revenues:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Direct Premiums | $756514 | $774500 | $779490 | $789325 | $793254 | $803453 | $804586 | $807796 | $18471 | 2.3% | $3099828 | $3209088 | $109260 | 3.5% |
| &nbsp;&nbsp;Premiums ceded to IPO coinsurers (1) | (249944) | (246874) | (241439) | (239828) | (234614) | (231805) | (226869) | (224240) | 15589 | 6.5% | (978085) | (917527) | 60558 | 6.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted direct premiums (2) | 506570 | 527626 | 538051 | 549496 | 558640 | 571648 | 577717 | 583556 | 34060 | 6.2% | 2121743 | 2291561 | 169818 | 8.0% |
| &nbsp;&nbsp;Other ceded premiums (3) | (144606) | (165154) | (158397) | (163356) | (163832) | (185601) | (176548) | (179935) | (16578) | -10.1% | (631513) | (705915) | (74403) | -11.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net premiums | 361964 | 362472 | 379654 | 386140 | 394808 | 386047 | 401169 | 403621 | 17481 | 4.5% | 1490231 | 1585646 | 95415 | 6.4% |
| &nbsp;&nbsp;Allocated net investment income | 8253 | 8751 | 9320 | 10162 | 11445 | 12286 | 13241 | 14187 | 4025 | 39.6% | 36486 | 51160 | 14674 | 40.2% |
| &nbsp;&nbsp;Other, net | 11810 | 12315 | 12476 | 12369 | 12175 | 12374 | 13419 | 12352 | (17) | -0.1% | 48970 | 50320 | 1350 | 2.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenues | 382028 | 383537 | 401450 | 408672 | 418428 | 410707 | 427830 | 430161 | 21489 | 5.3% | 1575687 | 1687126 | 111439 | 7.1% |
| **Benefits and expenses:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Benefits and claims | 178963 | 162488 | 179696 | 182749 | 182903 | 148977 | 167356 | 150294 | (32455) | -17.8% | 703897 | 649530 | (54366) | -7.7% |
| &nbsp;&nbsp;Amortization of DAC | 62584 | 52235 | 59287 | 67344 | 81883 | 79668 | 88275 | 93099 | 25755 | 38.2% | 241451 | 342925 | 101475 | 42.0% |
| &nbsp;&nbsp;Insurance commissions | 4869 | 4785 | 4345 | 4458 | 3793 | 3854 | 3964 | 3724 | (734) | -16.5% | 18457 | 15335 | (3122) | -16.9% |
| &nbsp;&nbsp;Insurance expenses | 47375 | 47252 | 50534 | 52102 | 58272 | 58329 | 56471 | 57723 | 5622 | 10.8% | 197262 | 230796 | 33534 | 17.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benefits and expenses | 293792 | 266760 | 293862 | 306652 | 326851 | 290829 | 316066 | 304839 | (1813) | -0.6% | 1161066 | 1238587 | 77521 | 6.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | $88236 | $116778 | $107589 | $102019 | $91577 | $119878 | $111763 | $125321 | $23302 | 22.8% | $414621 | $448540 | $33918 | 8.2% |
| **Total Term Life Insurance - Financial Analysis** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Post-IPO direct premiums (4) | $401106 | $420865 | $431022 | $440490 | $448657 | $460061 | $465354 | $469565 | $29075 | 6.6% | $1693483 | $1843637 | $150154 | 8.9% |
| Pre-IPO direct premiums (5) | 355408 | 353635 | 348468 | 348834 | 344597 | 343392 | 339232 | 338230 | (10604) | -3.0% | 1406345 | 1365451 | (40894) | -2.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total direct premiums | $756514 | $774500 | $779490 | $789325 | $793254 | $803453 | $804586 | $807796 | $18471 | 2.3% | $3099828 | $3209088 | $109260 | 3.5% |
| Premiums ceded to IPO coinsurers | $249944 | $246874 | $241439 | $239828 | $234614 | $231805 | $226869 | $224240 | $(15589) | -6.5% | $978085 | $917527 | $(60558) | -6.2% |
| &nbsp;&nbsp;% of Pre-IPO direct premiums | 70.3% | 69.8% | 69.3% | 68.8% | 68.1% | 67.5% | 66.9% | 66.3% | nm | nm | 69.5% | 67.2% | nm | nm |
| Benefits and claims, net (6) | $323569 | $327642 | $338093 | $346105 | $346735 | $334578 | $343904 | $330228 | $(15877) | -4.6% | $1335409 | $1355446 | $20036 | 1.5% |
| &nbsp;&nbsp;% of adjusted direct premiums | 63.9% | 62.1% | 62.8% | 63.0% | 62.1% | 58.5% | 59.5% | 56.6% | nm | nm | 62.9% | 59.1% | nm | nm |
| DAC amortization & insurance commissions | $67454 | $57020 | $63632 | $71802 | $85676 | $83523 | $92239 | $96823 | $25020 | 34.8% | $259908 | $358261 | $98353 | 37.8% |
| &nbsp;&nbsp;% of adjusted direct premiums | 13.3% | 10.8% | 11.8% | 13.1% | 15.3% | 14.6% | 16.0% | 16.6% | nm | nm | 12.2% | 15.6% | nm | nm |
| Insurance expenses, net (7) | $35565 | $34937 | $38057 | $39732 | $46097 | $45955 | $43052 | $45371 | $5639 | 14.2% | $148291 | $180476 | $32184 | 21.7% |
| &nbsp;&nbsp;% of adjusted direct premiums | 7.0% | 6.6% | 7.1% | 7.2% | 8.3% | 8.0% | 7.5% | 7.8% | nm | nm | 7.0% | 7.9% | nm | nm |
| Total Term Life income before income taxes | $88236 | $116778 | $107589 | $102019 | $91577 | $119878 | $111763 | $125321 | $23302 | 22.8% | $414621 | $448540 | $33918 | 8.2% |
| &nbsp;&nbsp;Term Life operating margin (8) | 17.4% | 22.1% | 20.0% | 18.6% | 16.4% | 21.0% | 19.3% | 21.5% | nm | nm | 19.5% | 19.6% | nm | nm |

---

------

(1) <u>Premiums ceded to IPO coinsurers</u> - premiums ceded to IPO coinsurers under the IPO coinsurance transactions excluding any reimbursements from the IPO coinsurers on previously existing reinsurance agreements.

(2) <u>Adjusted direct premiums</u> - direct premiums net of premiums ceded to IPO coinsurers.

(3) <u>Other ceded premiums</u> - premiums ceded to non-IPO coinsurers net of any applicable reimbursements from the IPO coinsurers.

(4) <u>Post-IPO direct premiums</u> - direct premiums not subject to the 2010 IPO coinsurance transactions.

(5) <u>Pre-IPO direct premiums</u> - direct premiums subject to the 2010 IPO coinsurance transactions.

(6) <u>Benefits and claims, net</u> - benefits & claims net of other ceded premiums which are largely YRT.

(7) <u>Insurance expenses, net</u> - insurance expenses net of other, net revenues.

(8) <u>Term Life operating margin</u> - Term Life operating income before income taxes as a percentage of adjusted direct premiums.

9 of 18

------

---

| | |
|:---|:---|
| **Term Life Insurance - Key Statistics** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands, except as noted) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$/#<br>Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$/#<br>Change** | **%<br>Change** |
| **Key Statistics** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Life-insurance licensed sales force, beginning of period | 134907 | 132030 | 132041 | 130023 | 129515 | 130206 | 132149 | 134313 | 4290 | 3.3% | 134907 | 129515 | (5392) | -4.0% |
| New life-licensed representatives | 10833 | 10112 | 9381 | 9296 | 9983 | 11529 | 12518 | 11117 | 1821 | 19.6% | 39622 | 45147 | 5525 | 13.9% |
| Non-renewal and terminated representatives | (13710) | (10101) | (11399) | (9804) | (9292) | (9586) | (10354) | (10222) | (418) | -4.3% | (45014) | (39454) | 5560 | 12.4% |
| Life-insurance licensed sales force, end of period | 132030 | 132041 | 130023 | 129515 | 130206 | 132149 | 134313 | 135208 | 5693 | 4.4% | 129515 | 135208 | 5693 | 4.4% |
| Estimated annualized issued term life premium ($mills) (1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Premium from new policies | $74.5 | $82.6 | $70.7 | $69.4 | $65.5 | $72.3 | $68.0 | $66.0 | $(3.4) | -4.9% | $297.2 | $271.9 | $(25.4) | -8.5% |
| Additions and increases in premium | 18.0 | 20.3 | 19.5 | 19.1 | 18.4 | 20.6 | 19.5 | 18.2 | (0.9) | -4.8% | 77.0 | 76.7 | (0.3) | -0.4% |
| Total estimated annualized issued term life premium | $92.5 | $103.0 | $90.2 | $88.5 | $83.8 | $92.9 | $87.5 | $84.2 | $(4.3) | -4.9% | $374.2 | $348.5 | $(25.7) | -6.9% |
| Issued term life policies | 82667 | 90071 | 75914 | 75203 | 71324 | 76946 | 71104 | 72544 | (2659) | -3.5% | 323855 | 291918 | (31937) | -9.9% |
| Estimated average annualized issued term life premium per policy (1)(2) | $901 | $917 | $931 | $923 | $918 | $940 | $957 | $910 | $(13) | -1.4% | $918 | $931 | $14 | 1.5% |
| Term life face amount in-force, beginning of period ($mills) | $858818 | $869643 | $886519 | $894018 | $903404 | $909632 | $914438 | $912785 | $18767 | 2.1% | $858818 | $903404 | $44586 | 5.2% |
| Issued term life face amount (3) | 26643 | 29981 | 26219 | 25678 | 24773 | 27651 | 26049 | 25349 | (329) | -1.3% | 108521 | 103822 | (4699) | -4.3% |
| Terminated term life face amount | (17240) | (14706) | (16241) | (16610) | (19787) | (19298) | (21033) | (22776) | (6166) | -37.1% | (64798) | (82894) | (18096) | -27.9% |
| Foreign currency impact, net | 1422 | 1602 | (2480) | 319 | 1242 | (3547) | (6669) | 1450 | 1131 | nm | 862 | (7524) | (8386) | nm |
| Term life face amount in-force, end of period | $869643 | $886519 | $894018 | $903404 | $909632 | $914438 | $912785 | $916808 | $13404 | 1.5% | $903404 | $916808 | $13404 | 1.5% |

---

------

(1) <u>Estimated annualized issued term life premium</u> - estimated as average premium per $1,000 of face amounts issued on new policies and additions (before free look returns) multiplied by actual face amount issued on new policies, rider additions and face amount increases.

(2) In whole dollars.

(3) <u>Issued term life face amount</u> - includes face amount on issued term life policies, additional riders added to existing policies, and face increases under increasing benefit riders.

10 of 18

------

---

| | |
|:---|:---|
| **Investment and Savings Products - Financial Results and Financial Analysis**  | <br>**PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands, except as noted) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Investment & Savings Products Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| **Revenues:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Commissions and fees: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales-based | $98112 | $104716 | $95229 | $103451 | $103242 | $88701 | $67962 | $66473 | $(36978) | -35.7% | $401508 | $326378 | $(75130) | -18.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-based | 101241 | 108490 | 113558 | 118015 | 113112 | 108101 | 107483 | 105357 | (12657) | -10.7% | 441303 | 434053 | (7250) | -1.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Account-based | 21120 | 21848 | 21456 | 22514 | 21541 | 22592 | 22910 | 23348 | 834 | 3.7% | 86939 | 90391 | 3453 | 4.0% |
| &nbsp;&nbsp;Other, net | 2949 | 2958 | 3094 | 3096 | 3144 | 3022 | 3342 | 3102 | 6 | 0.2% | 12097 | 12610 | 513 | 4.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenues | 223422 | 238012 | 233337 | 247076 | 241039 | 222416 | 201697 | 198280 | (48796) | -19.7% | 941848 | 863432 | (78415) | -8.3% |
| **Benefits and expenses:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Amortization of DAC | 3275 | 1786 | 2580 | 1027 | 3925 | 5463 | 2222 | 530 | (497) | -48.4% | 8668 | 12141 | 3473 | 40.1% |
| &nbsp;&nbsp;Insurance commissions | 3572 | 3747 | 3747 | 3839 | 3646 | 3450 | 3419 | 3320 | (519) | -13.5% | 14904 | 13834 | (1070) | -7.2% |
| &nbsp;&nbsp;Sales commissions: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales-based | 68594 | 73629 | 67745 | 77390 | 74606 | 63403 | 48775 | 47927 | (29463) | -38.1% | 287359 | 234711 | (52648) | -18.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-based | 46866 | 50488 | 53233 | 55614 | 53366 | 50876 | 51549 | 51047 | (4567) | -8.2% | 206201 | 206838 | 637 | 0.3% |
| &nbsp;&nbsp;Other operating expenses | 37752 | 37207 | 36664 | 38507 | 40936 | 40249 | 37355 | 38038 | (469) | -1.2% | 150130 | 156578 | 6448 | 4.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benefits and expenses | 160060 | 166858 | 163968 | 176377 | 176479 | 163440 | 143320 | 140863 | (35514) | -20.1% | 667263 | 624103 | (43160) | -6.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | $63363 | $71154 | $69369 | $70699 | $64560 | $58975 | $58377 | $57417 | $(13282) | -18.8% | $274585 | $239329 | $(35255) | -12.8% |
| **Financial Analysis** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Fees paid based on client asset values (1) | $6964 | $7535 | $7891 | $8482 | $8037 | $7917 | $7980 | $8004 | $(478) | -5.6% | $30872 | $31939 | $1067 | 3.5% |
| Fees paid based on fee-generating positions (2) | 10451 | 10021 | 9128 | 9852 | 10948 | 9974 | 9486 | 9665 | (188) | -1.9% | 39452 | 40073 | 621 | 1.6% |
| Other operating expenses | 20337 | 19652 | 19645 | 20172 | 21951 | 22358 | 19889 | 20369 | 197 | 1.0% | 79806 | 84567 | 4761 | 6.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other operating expenses | $37752 | $37207 | $36664 | $38507 | $40936 | $40249 | $37355 | $38038 | $(469) | -1.2% | $150130 | $156578 | $6448 | 4.3% |
| Sales-based net revenue as % of revenue-generating sales (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;U.S. | 1.29% | 1.28% | 1.25% | 1.11% | 1.20% | 1.27% | 1.23% | 1.21% | nm | nm | 1.23% | 1.23% | nm | nm |
| &nbsp;&nbsp;Canada | 1.05% | 0.96% | 0.92% | 0.65% | 1.00% | 0.78% | 0.32% | 0.31% | nm | nm | 0.91% | 0.77% | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 1.25% | 1.23% | 1.20% | 1.05% | 1.16% | 1.21% | 1.17% | 1.15% | nm | nm | 1.18% | 1.17% | nm | nm |
| Asset-based net revenue as % of average asset values (4) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;U.S. | 0.039% | 0.039% | 0.039% | 0.040% | 0.039% | 0.040% | 0.042% | 0.040% | nm | nm | 0.157% | 0.160% | nm | nm |
| &nbsp;&nbsp;Canada | 0.103% | 0.112% | 0.106% | 0.115% | 0.091% | 0.078% | 0.099% | 0.109% | nm | nm | 0.436% | 0.375% | nm | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 0.049% | 0.050% | 0.050% | 0.052% | 0.047% | 0.046% | 0.051% | 0.051% | nm | nm | 0.201% | 0.194% | nm | nm |
| Account-based net revenue per average fee generating position (5)(6) | $3.77 | $4.08 | $4.17 | $4.22 | $3.48 | $4.08 | $4.31 | $4 | nm | nm | $16.26 | $16.26 | nm | nm |

---

------

(1) <u>Fees paid based on client asset values</u> - administration fees on Canadian Segregated Funds and advisory fees on Managed Accounts that vary directly with client asset values.

(2) <u>Fees paid based on fee-generating positions</u> - recordkeeping fees that vary with the number of fee-generating positions.

(3) <u>Sales-based net revenue</u> - commission and fee revenue less commissions paid to the sales force based on product sales activity.

(4) <u>Asset-based net revenue</u> - commission and fee revenue less administration and advisory fees paid to third-party providers and commissions paid to the sales force earned based on product account values including amortization of deferred acquisition costs for segregated funds.

(5) <u>Account-based net revenue</u> - fee revenue less recordkeeping fees paid to third-party providers based on fee-generating positions and certain direct general expenses.

(6) In whole dollars.

11 of 18

------

---

| | |
|:---|:---|
| **Investment and Savings Products - Key Statistics** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands, except as noted) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$/#<br>Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$/#<br>Change** | **%<br>Change** |
| **Key Statistics** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| <u>Product sales</u> ($mills) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| U.S. Retail Mutual Funds | $1261.9 | $1336.1 | $1247.8 | $1300.3 | $1298.6 | $1151.4 | $931.8 | $883.8 | $(416.6) | -32.0% | $5146.1 | $4265.6 | $(880.5) | -17.1% |
| Canada Retail Mutual Funds | 424.0 | 357.0 | 314.8 | 343.0 | 437.6 | 250.6 | 112.2 | 112.0 | (231.0) | -67.4% | 1438.8 | 912.5 | (526.3) | -36.6% |
| Indexed Annuities | 55.5 | 62.8 | 51.9 | 60.1 | 57.5 | 70.2 | 55.8 | 69.2 | 9.0 | 15.0% | 230.2 | 252.6 | 22.3 | 9.7% |
| Variable Annuities and other | 627.1 | 767.6 | 668.7 | 782.2 | 668.4 | 617.3 | 542.5 | 548.0 | (234.3) | -30.0% | 2845.6 | 2376.2 | (469.4) | -16.5% |
| Total sales-based revenue generating product sales | 2368.4 | 2523.4 | 2283.1 | 2485.7 | 2462.1 | 2089.5 | 1642.3 | 1612.9 | (872.8) | -35.1% | 9660.7 | 7806.8 | (1853.9) | -19.2% |
| Managed Accounts | 330.1 | 381.8 | 387.5 | 406.3 | 453.7 | 451.3 | 319.6 | 288.1 | (118.2) | -29.1% | 1505.6 | 1512.8 | 7.1 | 0.5% |
| Canada Retail Mutual Funds - no upfront sales comm | 79.8 | 82.9 | 76.3 | 78.9 | 82.2 | 97.5 | 157.9 | 156.6 | 77.7 | 98.6% | 317.9 | 494.3 | 176.4 | 55.5% |
| Segregated Funds | 75.1 | 52.2 | 43.5 | 48.2 | 67.3 | 51.3 | 41.6 | 35.0 | (13.2) | -27.4% | 219.0 | 195.1 | (23.8) | -10.9% |
| Total product sales | $2853.5 | $3040.2 | $2790.4 | $3019.0 | $3065.4 | $2689.6 | $2161.5 | $2092.5 | $(926.5) | -30.7% | $11703.2 | $10009.0 | $(1694.2) | -14.5% |
| Total Canada Retail Mutual Funds | $503.9 | $439.9 | $391.1 | $421.9 | $519.9 | $348.1 | $270.2 | $268.6 | $(153.3) | -36.3% | $1756.7 | $1406.8 | $(349.9) | -19.9% |
| Segregated Funds | 75.1 | 52.2 | 43.5 | 48.2 | 67.3 | 51.3 | 41.6 | 35.0 | (13.2) | -27.4% | 219.0 | 195.1 | (23.8) | -10.9% |
| Total Canada product sales | 579.0 | 492.0 | 434.6 | 470.0 | 587.1 | 399.4 | 311.8 | 303.5 | (166.5) | -35.4% | 1975.6 | 1601.9 | (373.8) | -18.9% |
| Total U.S. product sales | 2274.5 | 2548.2 | 2355.8 | 2549.0 | 2478.2 | 2290.1 | 1849.7 | 1789.0 | (760.0) | -29.8% | 9727.5 | 8407.1 | (1320.4) | -13.6% |
| Total product sales | $2853.5 | $3040.2 | $2790.4 | $3019.0 | $3065.4 | $2689.6 | $2161.5 | $2092.5 | $(926.5) | -30.7% | $11703.2 | $10009.0 | $(1694.2) | -14.5% |
| Client asset values, beginning of period ($mills) | $81533 | $85888 | $91735 | $91765 | $97312 | $93708 | $82291 | $78737 | $(13028) | -14.2% | $81533 | $97312 | $15779 | 19.4% |
| Inflows | 2853 | 3040 | 2790 | 3019 | 3065 | 2690 | 2161 | 2093 | (926) | -30.7% | 11703 | 10009 | (1694) | -14.5% |
| Outflows (1) | (1759) | (1826) | (1756) | (1819) | (1900) | (1797) | (1447) | (1444) | 376 | 20.7% | (7161) | (6587) | 573 | 8.0% |
| Net flows | 1095 | 1214 | 1034 | 1200 | 1166 | 893 | 714 | 649 | (551) | -45.9% | 4543 | 3422 | (1121) | nm |
| Foreign currency impact, net | 172 | 200 | (323) | 42 | 171 | (474) | (802) | 174 | 133 | nm | 91 | (930) | (1021) | nm |
| Change in market value, net and other (2) | 3088 | 4433 | (681) | 4306 | (4941) | (11836) | (3466) | 4388 | 82 | 1.9% | 11146 | (15855) | (27001) | nm |
| Client asset values, end of period | $85888 | $91735 | $91765 | $97312 | $93708 | $82291 | $78737 | $83949 | $(13363) | -13.7% | $97312 | $83949 | $(13363) | -13.7% |
| Annualized net flows as % of beginning of period asset values | 5.4% | 5.7% | 4.5% | 5.2% | 4.8% | 3.8% | 3.5% | 3.3% | -1.9% | nm | 5.6% | 3.5% | -2.1% | nm |
| <u>Average client asset values</u> ($mills) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| U.S. Retail Mutual Funds | $41161 | $44398 | $46113 | $47139 | $46429 | $42870 | $40331 | $40402 | $(6737) | -14.3% | $44703 | $42508 | $(2195) | -4.9% |
| Canada Retail Mutual Funds | 10268 | 11256 | 11667 | 11984 | 12119 | 11539 | 10840 | 10759 | (1225) | -10.2% | 11294 | 11314 | 20 | 0.2% |
| Managed Accounts | 5295 | 5915 | 6362 | 6772 | 7077 | 6960 | 6817 | 6949 | 177 | 2.6% | 6086 | 6951 | 864 | 14.2% |
| Indexed Annuities | 2495 | 2541 | 2585 | 2620 | 2650 | 2677 | 2696 | 2710 | 90 | 3.4% | 2560 | 2683 | 123 | 4.8% |
| Variable Annuities and other | 21291 | 22554 | 23193 | 23567 | 23218 | 21431 | 20269 | 20137 | (3430) | -14.6% | 22651 | 21264 | (1388) | -6.1% |
| Segregated Funds | 2622 | 2713 | 2732 | 2727 | 2710 | 2517 | 2368 | 2299 | (428) | -15.7% | 2698 | 2474 | (225) | -8.3% |
| Total | $83131 | $89378 | $92652 | $94809 | $94203 | $87994 | $83320 | $83256 | $(11554) | -12.2% | $89993 | $87193 | $(2799) | -3.1% |
| Canada Retail Mutual Funds | $10268 | $11256 | $11667 | $11984 | $12119 | $11539 | $10840 | $10759 | $(1225) | -10.2% | $11294 | $11314 | $20 | 0.2% |
| Segregated Funds | 2622 | 2713 | 2732 | 2727 | 2710 | 2517 | 2368 | 2299 | (428) | -15.7% | 2698 | 2474 | (225) | -8.3% |
| Total Canada average client assets | 12890 | 13969 | 14399 | 14711 | 14829 | 14056 | 13208 | 13058 | (1654) | -11.2% | 13992 | 13788 | (205) | -1.5% |
| Total U.S. average client assets | 70241 | 75409 | 78252 | 80098 | 79374 | 73938 | 70112 | 70198 | (9900) | -12.4% | 76000 | 73405 | (2595) | -3.4% |
| Total average client assets | $83131 | $89378 | $92652 | $94809 | $94203 | $87994 | $83320 | $83256 | $(11554) | -12.2% | $89993 | $87193 | $(2799) | -3.1% |
| <u>Average number of fee-generating positions</u> (thous) (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Recordkeeping and custodial | 2115 | 2159 | 2192 | 2218 | 2243 | 2277 | 2295 | 2309 | 90 | 4.1% | 2171 | 2281 | 110 | 5.1% |
| Recordkeeping only | 714 | 741 | 762 | 780 | 797 | 812 | 820 | 825 | 45 | 5.8% | 749 | 814 | 65 | 8.6% |
| Total | 2830 | 2899 | 2954 | 2998 | 3040 | 3089 | 3115 | 3134 | 136 | 4.5% | 2920 | 3095 | 175 | 6.0% |

---

------

(1) <u>Asset value outflows</u> - include (a) redemptions of assets, (b) sales charges on the inflow sales figures, and (c) the net flow of money market funds sold and redeemed on the company's recordkeeping platform. The redemptions of assets must be estimated for approximately 4% of account values as these figures are not readily available. Actual redemptions as a percentage of account values for similar known account values are used to estimate the unknown redemption values.

(2) <u>Change in market value, net</u> - market value fluctuations net of fees and expenses.

(3) <u>Fee generating positions</u> - mutual fund positions for which we receive recordkeeping fees. An individual client account may include multiple mutual fund positions. We may also receive fees earned for custodial services that we provide to clients with retirement plan accounts that hold positions in these mutual funds.

12 of 18

------

---

| | |
|:---|:---|
| **Senior Health - Financial Results, Financial Analysis Key Statistics** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands, except as noted) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Senior Health Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| **Revenues:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commissions and fees (1) |  |  | $21558 | $29345 | $1278 | $9343 | $14601 | $22198 | $(7146 | -24.4% | $50903 | $47420 | $(3483 | -6.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net (2) |  |  | 1378 | 8159 | 4553 | 2471 | 2583 | 5655 | (2504 | -30.7% | 9537 | 15262 | 5724 | 60.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenues |  |  | 22937 | 37504 | 5831 | 11814 | 17183 | 27853 | (9650 | -25.7% | 60440 | 62682 | 2241 | 3.7% |
| **Benefits and expenses:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract acquisition costs (3) |  |  | 23524 | 29264 | 20649 | 19384 | 13446 | 14952 | (14312 | -48.9% | 52788 | 68431 | 15643 | 29.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted other operating expenses |  |  | 7485 | 8411 | 7868 | 8514 | 7461 | 8617 | 206 | 2.4% | 15895 | 32459 | 16563 | 104.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating benefits and expenses |  |  | 31009 | 37675 | 28517 | 27898 | 20907 | 23568 | (14107 | -37.4% | 68684 | 100889 | 32206 | 46.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes including NCI |  |  | $(8072 | $(171 | $(22686 | $(16084 | $(3723 | $4285 | $4457 | nm | $(8243 | $(38208 | $(29964 | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interest before income taxes |  |  | (1465 | (540 | (3668 | (3129 |  |  | 540 | 100.0% | (2005 | (6797 | (4792 | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes attributable to Primerica, Inc. |  |  | $(6608 | $369 | $(19018 | $(12955 | $(3723 | $4285 | $3917 | nm | $(6239 | $(31411 | $(25172 | nm |
| **Senior Health EBITDA** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes including NCI |  |  | $(8072 | $(171 | $(22686 | $(16084 | $(3723 | $4285 | $4457 | nm | $(8243 | $(38208 | $(29964 | nm |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Amortization of intangibles |  |  | (2900 | (2900 | (2600 | (2800 | (2800 | (2800 | 100 | 3.4% | (5800 | (11000 | (5200 | -89.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Depreciation |  |  | (244 | (249 | (245 | (226 | (221 | (211 | 38 | 15.1% | (493 | (903 | (409 | -83.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA (Including non-controlling interest) (4) |  |  | $(4928 | $2978 | $(19841 | $(13058 | $(703 | $7297 | $4319 | 145.0% | $(1950 | $(26305 | $(24355 | nm |
| **Financial Analysis and Key Statistics** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Senior Health submitted policies (5) |  |  | 20867 | 39142 | 26231 | 19652 | 16095 | 23060 | (16082 | -41.1% | 60009 | 85038 | 25029 | 41.7% |
| Senior Health approved policies (6) |  |  | 18276 | 32047 | 23594 | 17925 | 14862 | 20705 | (11342 | -35.4% | 50323 | 77086 | 26763 | 53.2% |
| Primerica representatives Senior Health certified |  |  | 17588 | 26441 | 42147 | 60412 | 83280 | 93348 | 66907 | nm | 26441 | 93348 | 66907 | nm |
| Senior Health submitted policies sourced by Primerica representatives |  |  | 319 | 4175 | 988 | 831 | 1016 | 5666 | 1491 | 35.7% | 4494 | 8501 | 4007 | 89.2% |
| LTV per approved policy (7) |  |  | $1180 | $1069 | $862 | $820 | $868 | $888 | $(181 | -17.0% | $1109 | $860 | $(249 | -22.4% |
| CAC per approved policy (7) |  |  | $1287 | $913 | $875 | $1081 | $905 | $722 | $(191 | -20.9% | $1049 | $888 | $(161 | -15.4% |
| LTV / CAC multiple |  |  | 0.9 | 1.2 | 1.0 | 0.8 | 1.0 | 1.2 | 0.1 | nm | 1.1 | 1.0 | -0.1 | nm |

---

------

(1) Commission revenue recognized based on the estimated Lifetime value (LTV) to be collected over the estimated life of an approved policy for the relevant period based on multiple factors, including but not limited to contracted commission rates, carrier mix, expected policy turnover, historical chargeback activity and applied constraints. Adjustments to revenue outside of LTV for approved policies from prior periods are recognized when our cash collections are different from the estimated constrained LTV's which we refer to as tail revenue.

(2) Primarily reflects marketing development revenues, which are non-commission revenues received from carriers to support marketing efforts and lead acquisition.

(3) <u>Contract acquisition costs (CAC)</u> - Includes direct marketing costs incurred to acquire leads through internal and external sources, including commissions paid to Primerica representatives, as well as ETQ agent compensation, training and licensing costs.

(4) <u>Adjusted EBITDA</u> - Earnings before interest, taxes, depreciation, amortization and certain adjustments for non-cash or non-recurring expenses including purchase accounting adjustments.

(5) <u>Senior Health submitted policies</u> - represents the number of completed applications that, with respect to each such application, the applicant has authorized us to submit to the health insurance carrier. The applicant may need to take additional actions, including providing subsequent information before the application is reviewed by the health insurance carrier.

(6) <u>Senior Health approved policies</u> - represent an estimate of submitted policies approved by health insurance carriers during the indicated period. Not all approved policies will go in force.

(7) In whole dollars.

13 of 18

------

---

| | |
|:---|:---|
| **Corporate Other Distributed Products - Financial Results** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |  | **YOY YTD** | **YOY YTD** |
| (Dollars in thousands) | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** | **$ Change** | **%<br>Change** | **YTD <br>2021** | **YTD <br>2022** | **$ Change** | **%<br>Change** |
| **Corporate & Other Distributed Products Income Before Income Taxes** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| **Revenues:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Direct premiums | $5713 | $5800 | $5788 | $5020 | $5412 | $5441 | $5494 | $4685 | $(334) | -6.7% | $22320 | $21032 | $(1288) | -5.8% |
| Ceded premiums | (1423) | (1822) | (1459) | (1963) | (1439) | (1642) | (1454) | (1914) | 49 | 2.5% | (6666) | (6449) | 217 | 3.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net premiums | 4290 | 3978 | 4328 | 3057 | 3973 | 3799 | 4040 | 2772 | (285) | -9.3% | 15654 | 14583 | (1071) | -6.8% |
| Allocated net investment income | 12592 | 11954 | 11321 | 10738 | 9559 | 10252 | 11173 | 14752 | 4015 | 37.4% | 46604 | 45736 | (869) | -1.9% |
| Commissions and fees: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid Legal Services | 4783 | 5182 | 6712 | 4085 | 4287 | 4664 | 5672 | 3821 | (263) | -6.4% | 20761 | 18444 | (2316) | -11.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Auto and Homeowners Insurance | 1787 | 2101 | 2436 | 1971 | 1591 | 2056 | 2647 | 1994 | 24 | 1.2% | 8295 | 8289 | (7) | -0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans | 4960 | 6061 | 6719 | 6598 | 4818 | 3128 | 2103 | 1656 | (4941) | -74.9% | 24337 | 11705 | (12632) | -51.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other sales commissions | 2041 | 2291 | 2129 | 2307 | 1932 | 2103 | 2090 | 1872 | (435) | -18.9% | 8767 | 7996 | (771) | -8.8% |
| Other, net | 836 | 1040 | 1101 | 992 | 1117 | 889 | 1621 | 1341 | 349 | 35.2% | 3969 | 4967 | 998 | 25.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating revenues | 31288 | 32607 | 34746 | 29746 | 27276 | 26890 | 29345 | 28209 | (1538) | -5.2% | 128387 | 111720 | (16668) | -13.0% |
| **Benefits and expenses:** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Benefits and claims | 4826 | 5859 | 3728 | 4443 | 4166 | 4280 | 3937 | 3836 | (607) | -13.7% | 18856 | 16218 | (2638) | -14.0% |
| Amortization of DAC | 246 | 264 | 347 | 203 | 255 | 247 | 427 | 146 | (57) | -28.0% | 1060 | 1077 | 16 | 1.5% |
| Insurance commissions | 299 | 306 | 320 | 246 | 282 | 290 | 283 | 237 | (9) | -3.7% | 1171 | 1092 | (79) | -6.7% |
| Insurance expenses | 1391 | 1327 | 1367 | 1257 | 1237 | 1132 | 1081 | 1160 | (97) | -7.7% | 5343 | 4609 | (733) | -13.7% |
| Sales commissions | 6434 | 7185 | 8290 | 6839 | 5952 | 5484 | 5592 | 4187 | (2652) | -38.8% | 28748 | 21215 | (7533) | -26.2% |
| Interest expense | 7145 | 7141 | 7529 | 8804 | 6853 | 6814 | 6802 | 6768 | (2035) | -23.1% | 30618 | 27237 | (3381) | -11.0% |
| Adjusted other operating expenses | 35211 | 27413 | 26695 | 30301 | 36475 | 30530 | 28974 | 33788 | 3487 | 11.5% | 119621 | 129766 | 10145 | 8.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted benefits and expenses | 55551 | 49495 | 48277 | 52093 | 55219 | 48777 | 47096 | 50123 | (1970) | -3.8% | 205416 | 201214 | (4202) | -2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income before income taxes | $(24263) | $(16888) | $(13531) | $(22346) | $(27943) | $(21887) | $(17750) | $(21914) | $432 | 1.9% | $(77029) | $(89495) | $(12466) | -16.2% |

---

14 of 18

------

---

| | |
|:---|:---|
| **Investment Portfolio - Summary of Holdings** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of or for the period ended December 31, 2022** | **As of or for the period ended December 31, 2022** | **As of or for the period ended December 31, 2022** | **As of or for the period ended December 31, 2022** | **As of or for the period ended December 31, 2022** | **As of or for the period ended December 31, 2022** |
|  |  |  | **% of Total** | **% of Total** | **Avg** |  |
|  | **Market** | **Unrealized** | **Market** | **Amortized** | **Book** | **Avg** |
| (Dollars in thousands) | **Value** | **G/(L)** | **Value** | **Cost** | **Yield** | **Rating** |
| **Investment Portfolio by Asset Class** |  |  |  |  |  |  |
| **Cash, Cash Equivalents, and Short Term** | $558646 | $- | 18.1% | 16.4% |  |  |
| **Fixed Income:** |  |  |  |  |  |  |
| Treasury | 41741 | (889) | 1.3% | 1.3% | 1.31% | AAA |
| Government | 231004 | (26414) | 7.5% | 7.6% | 2.98% | AA- |
| Tax-Exempt Municipal | 32883 | (4201) | 1.1% | 1.1% | 2.69% | AA |
| Corporate | 1229921 | (140645) | 39.8% | 40.3% | 3.55% | BBB+ |
| Mortgage Backed | 414043 | (72050) | 13.4% | 14.3% | 2.92% | AAA |
| Asset Backed | 155397 | (16413) | 5.0% | 5.1% | 3.70% | AA |
| Cmbs | 122967 | (16339) | 4.0% | 4.1% | 3.39% | AA- |
| Private | 267612 | (28345) | 8.7% | 8.7% | 4.46% | BBB |
| Redeemable Preferred | 3586 | (662) | 0.1% | 0.1% | 5.27% | BBB- |
| Total Fixed Income | 2499154 | (305959) | 80.8% | 82.5% | 3.44% | A |
| **Equities and Other:** |  |  |  |  |  |  |
| Perpetual Preferred | 8651 | - | 0.3% | 0.3% |  |  |
| Common Stock | 20958 | (0) | 0.7% | 0.6% |  |  |
| Mutual Fund | 5795 | 0 | 0.2% | 0.2% |  |  |
| Total Equities | 35404 | (0) | 1.1% | 1.0% |  |  |
| Total Invested Assets | $3093205 | $(305959) | 100.0% | 100.0% |  |  |
| **Public Corporate Portfolio by Sector** |  |  |  |  |  |  |
| Insurance | $154034 | $(20592) | 12.5% | 12.7% |  |  |
| Consumer Non Cyclical | 131027 | (16334) | 10.7% | 10.8% |  |  |
| Energy | 127361 | (13421) | 10.4% | 10.3% |  |  |
| Reits | 118000 | (17921) | 9.6% | 9.9% |  |  |
| Consumer Cyclical | 103177 | (11512) | 8.4% | 8.4% |  |  |
| Banking | 97588 | (5827) | 7.9% | 7.5% |  |  |
| Technology | 93443 | (8565) | 7.6% | 7.4% |  |  |
| Capital Goods | 62874 | (5680) | 5.1% | 5.0% |  |  |
| Basic Industry | 60439 | (7558) | 4.9% | 5.0% |  |  |
| Electric | 55377 | (6209) | 4.5% | 4.5% |  |  |
| Finance Companies | 55140 | (7639) | 4.5% | 4.6% |  |  |
| Transportation | 54942 | (5663) | 4.5% | 4.4% |  |  |
| Communications | 44182 | (4355) | 3.6% | 3.5% |  |  |
| Brokerage | 44124 | (5633) | 3.6% | 3.6% |  |  |
| Financial Other | 8638 | (946) | 0.7% | 0.7% |  |  |
| Natural Gas | 7188 | (551) | 0.6% | 0.6% |  |  |
| Industrial Other | 5951 | (964) | 0.5% | 0.5% |  |  |
| Utility Other | 4583 | (805) | 0.4% | 0.4% |  |  |
| Owned No Guarantee | 1854 | (471) | 0.2% | 0.2% |  |  |
| Total Corporate portfolio | $1229921 | $(140645) | 100.0% | 100.0% |  |  |
| **Fixed-Maturity Securities - Effective Maturity** |  |  |  |  |  |  |
| Effective maturity |  |  |  |  |  |  |
| < 1 Yr. | $190479 | $(2088) | 7.6% | 6.9% | 3.15% |  |
| 1-2 Yrs. | 271286 | (9253) | 10.9% | 10.0% | 3.63% |  |
| 2-5 Yrs. | 781492 | (64497) | 31.3% | 30.2% | 3.67% |  |
| 5-10 Yrs. | 980174 | (169798) | 39.2% | 41.0% | 3.25% |  |
| > 10 Yrs. | 275724 | (60323) | 11.0% | 12.0% | 3.54% |  |
| Total Fixed Income | $2499154 | $(305959) | 100.0% | 100.0% | 3.44% |  |
| **Duration** |  |  |  |  |  |  |
| Fixed Income portfolio duration | 4.7 |  |  |  |  |  |

---

------

Note: Investment Portfolio pages in this Financial Supplement exclude the Held to Maturity asset on our balance sheet.

15 of 18

------

---

| | |
|:---|:---|
| **Investment Portfolio - Quality Ratings As of December 31, 2022** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| (Dollars in thousands) |  |  |  |  |  |
| **Investment Portfolio Quality Ratings (1)** |  |  |  |  |  |
|  | **Amortized Cost** | **% of Total** |  |  |  |
| **Total Fixed Income portfolio:** |  |  |  |  |  |
| <u>Rating</u> |  |  |  |  |  |
| AAA | $606982 | 21.6% |  |  |  |
| AA | 321450 | 11.5% |  |  |  |
| A | 688936 | 24.6% |  |  |  |
| BBB | 1120096 | 39.9% |  |  |  |
| Below Investment Grade | 67450 | 2.4% |  |  |  |
| NA | 199 | 0.0% |  |  |  |
| Total Fixed Income | $2805113 | 100.0% |  |  |  |
|  | **Amortized Cost** | **% of Total** |  | **Amortized Cost** | **% of Total** |
| **Public Corporate asset class:** |  |  | **Private Placement asset class:** |  |  |
| <u>Rating</u> |  |  | <u>Rating</u> |  |  |
| AAA | $11835 | 0.9% | AAA | $- |  |
| AA | 67985 | 5.0% | AA | 5274 | 1.8% |
| A | 356459 | 26.0% | A | 66034 | 22.3% |
| BBB | 872920 | 63.7% | BBB | 222819 | 75.3% |
| Below Investment Grade | 61192 | 4.5% | Below Investment Grade | 1830 | 0.6% |
| NA | 176 | 0.0% | NA | - |  |
| Total Corporate | $1370566 | 100.0% | Total Private | $295957 | 100.0% |
| **CMBS asset class:** |  |  | **Mortgage-Backed asset class:** |  |  |
| <u>Rating</u> |  |  | <u>Rating</u> |  |  |
| AAA | $60409 | 43.4% | AAA | $435692 | 89.6% |
| AA | 8930 | 6.4% | AA | 50170 | 10.3% |
| A | 69968 | 50.2% | A | 135 | 0.0% |
| BBB | - |  | BBB | - |  |
| Below Investment Grade | - |  | Below Investment Grade | 73 | 0.0% |
| NA | - |  | NA | 23 | 0.0% |
| Total CMBS | $139306 | 100.0% | Total Mortgage-Backed | $486093 | 100.0% |
| **Asset-Backed asset class:** |  |  | **Treasury & Government asset classes:** |  |  |
| <u>Rating</u> |  |  | <u>Rating</u> |  |  |
| AAA | $35245 | 20.5% | AAA | $63108 | 21.0% |
| AA | 9466 | 5.5% | AA | 151320 | 50.4% |
| A | 117409 | 68.3% | A | 71904 | 24.0% |
| BBB | 7964 | 4.6% | BBB | 11088 | 3.7% |
| Below Investment Grade | 1727 | 1.0% | Below Investment Grade | 2629 | 0.9% |
| NA | - |  | NA | - |  |
| Total Asset-Backed | $171811 | 100.0% | Total Treasury & Government | $300047 | 100.0% |
| **NAIC Designations** |  |  |  |  |  |
| 1 | $1357429 | 54.8% |  |  |  |
| 2 | 1038960 | 42.0% |  |  |  |
| 3 | 71518 | 2.9% |  |  |  |
| 4 | 7813 | 0.3% |  |  |  |
| 5 | 691 | 0.0% |  |  |  |
| 6 | 0 | 0.0% |  |  |  |
| U.S. Insurer Fixed Income (2) | 2476411 | 100.0% |  |  |  |
| Other (3) | 364107 |  |  |  |  |
| Cash and cash equivalents | 558646 |  |  |  |  |
| Total Invested Assets | $3399164 |  |  |  |  |

---

------

(1) Ratings method for split ratings: If by 2 NRSROs, use lower of the two; if by 3 or more NRSROs, use second lowest.

(2) NAIC ratings for our U.S. insurance companies' fixed income portfolios.

(3) Other consists of assets held by our non-life companies, Canadian insurance company, and unrated equities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Note: Investment Portfolio pages in this Financial Supplement exclude the Held to Maturity asset on our balance sheet.

16 of 18

------

---

| | |
|:---|:---|
| **Investment Portfolio - Supplemental Data and Trends** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** | **YOY Q4** |
| (Dollars in thousands) | **Q1 <br>2021** | **Q2 <br>2021** | **Q3 <br>2021** | **Q4 <br>2021** | **Q1 <br>2022** | **Q2 <br>2022** | **Q3 <br>2022** | **Q4 <br>2022** | **$ Change** | **$Change** | **%<br>Change** |
| **Net Investment Income by Source** |  |  |  |  |  |  |  |  |  |  |  |
| Fixed-maturity securities (available-for-sale) | $20020 | $20155 | $19860 | $20328 | $20889 | $22414 | $23067 | $24605 | $| 4277 | 21.0% |
| Fixed-maturity securities (held-to-maturity) | 15146 | 15495 | 15741 | 15825 | 15515 | 15815 | 16283 | 16309 |  | 484 | 3.1% |
| Equity Securities | 391 | 411 | 413 | 416 | 387 | 371 | 373 | 377 |  | (39) | -9.3% |
| Deposit asset underlying 10% reinsurance treaty | 1368 | 1238 | 987 | 785 | 589 | 485 | 557 | 2134 |  | 1350 | 172.0% |
| Deposit asset - Mark to Market | (793) | (170) | (640) | (899) | (2099) | (1254) | (68) | (409) |  | 490 | -54.5% |
| Policy loans and other invested assets | 231 | 98 | 289 | 401 | 102 | 58 | 436 | 450 |  | 49 | 12.3% |
| Cash & cash equivalents | 119 | 156 | 96 | 85 | 125 | 498 | 1714 | 3605 |  | 3520 | 4141.4% |
| Total investment income | 36483 | 37383 | 36746 | 36940 | 35508 | 38387 | 42362 | 47072 |  | 10132 | 27.4% |
| Investment expenses | 1284 | 1353 | 1004 | 1114 | 1088 | 1288 | 1733 | 2233 |  | 1119 | 100.4% |
| Interest Expense on Surplus Note | 15146 | 15495 | 15741 | 15825 | 15515 | 15815 | 16283 | 16309 |  | 484 | 3.1% |
| Net investment income | $20052 | $20535 | $20001 | $20001 | $18905 | $21284 | $24346 | $28530 | $| 8529 | 42.6% |
| Fixed income book yield, end of period | 3.30% | 3.31% | 3.23% | 3.12% | 3.18% | 3.25% | 3.34% | 3.44% |  |  |  |
| New money yield | 1.72% | 2.68% | 2.21% | 1.60% | 3.37% | 4.21% | 3.93% | 5.41% |  |  |  |
|  |  |  |  |  |  |  |  |  | **YOY Q4** | **YOY Q4** |  |
|  | **Q1 <br>2021** | **Q2 <br>2021** | **Q3 <br>2021** | **Q4 <br>2021** | **Q1 <br>2022** | **Q2 <br>2022** | **Q3 <br>2022** | **Q4 <br>2022** | **% Pt<br>Change** | **% Pt<br>Change** |  |
| **Fixed Income Portfolio Quality Ratings** |  |  |  |  |  |  |  |  |  |  |  |
| <u>Rating</u> |  |  |  |  |  |  |  |  |  |  |  |
| AAA | 16.6% | 16.5% | 18.0% | 18.7% | 21.0% | 22.0% | 21.5% | 21.6% |  | 2.9% |  |
| AA | 12.2% | 11.6% | 11.0% | 11.8% | 11.2% | 11.2% | 11.1% | 11.5% |  | -0.3% |  |
| A | 23.0% | 22.1% | 23.6% | 24.4% | 23.7% | 23.0% | 23.0% | 24.6% |  | 0.2% |  |
| BBB | 44.0% | 45.5% | 42.9% | 40.8% | 39.8% | 39.6% | 40.1% | 39.9% |  | -0.9% |  |
| Below Investment Grade | 4.1% | 4.2% | 4.1% | 3.5% | 3.1% | 2.8% | 2.7% | 2.4% |  | -1.1% |  |
| NA | 0.1% | 0.1% | 0.3% | 0.8% | 1.2% | 1.3% | 1.5% | 0.0% |  | -0.8% |  |
| Total Fixed Income | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |  |  |  |
| Average rating by amortized cost | A- | A- | A | A | A | A | A | A |  |  |  |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **As of December 31, 2022** | **As of December 31, 2022** | **As of December 31, 2022** |  |  | **As of December 31, 2022** | **As of December 31, 2022** |  | **As of December 31, 2022** | **As of December 31, 2022** |
|  |  | **Market<br>Value** | **Amortized<br>Cost** | **Credit<br>Rating** |  |  | **Market<br>Value** | **Amortized<br>Cost** |  | **Market<br>Value** | **Amortized<br>Cost** |
| **Top 25 Exposures** | **Top 25 Exposures** |  |  |  | **Foreign Exposure (1)** | **Foreign Exposure (1)** |  |  | **Government Investments (1)** |  |  |
| 1 | Canada | $20709 | $22122 | AAA | Canada | Canada | $87091 | $97039 | AAA | $2000 | $2121 |
| 2 | Province of Quebec Canada | 16052 | 16658 | A+ | Australia | Australia | 21060 | 22497 | AA | 4742 | 4749 |
| 3 | Province of Ontario Canada | 14139 | 14708 | AA | United Kingdom | United Kingdom | 18418 | 18985 | A | 9070 | 10904 |
| 4 | Ontario Teachers' Pension Plan | 12538 | 14327 | AA+ | France | France | 8720 | 9256 | BBB | 9552 | 10638 |
| 5 | Province of Alberta Canada | 11727 | 12819 | BBB+ | Mexico | Mexico | 7895 | 9355 | Below Investment Grade | 2160 | 2629 |
| 6 | Morgan Stanley | 11304 | 11782 | BBB+ | Cayman Islands | Cayman Islands | 6464 | 8201 | NA |  |  |
| 7 | Manulife Financial Corp | 10603 | 11592 | A | Bermuda | Bermuda | 6373 | 6853 | Total | $27524 | $31040 |
| 8 | TC Energy Corp | 10240 | 11656 | BBB+ | Ireland | Ireland | 6041 | 6235 |  |  |  |
| 9 | ConocoPhillips | 9249 | 10697 | A | Japan | Japan | 5437 | 5474 |  |  |  |
| 10 | Province of Saskatchewan Canada | 9247 | 9634 | AA | Netherlands | Netherlands | 5293 | 5450 | **Non-Government Investments (1)** |  |  |
| 11 | Enbridge Inc | 8998 | 9878 | BBB+ | Malta | Malta | 5231 | 5466 |  |  |  |
| 12 | Kemper Corp | 8216 | 9094 | BBB | Israel | Israel | 4717 | 4825 | AAA | $2909 | $2999 |
| 13 | Fairfax Financial Holdings Ltd | 8182 | 9815 | BBB- | Brazil | Brazil | 3516 | 3557 | AA | 2305 | 2412 |
| 14 | Brookfield Corp | 8142 | 8500 | A- | Norway | Norway | 2884 | 3144 | A | 42393 | 45565 |
| 15 | Intact Financial Corp | 7924 | 7873 | A+ | Supranational | Supranational | 2747 | 2750 | BBB | 139079 | 150125 |
| 16 | City of Toronto Canada | 7821 | 8132 | AA | Emerging Markets (2) | Emerging Markets (2) | 11424 | 13080 | Below Investment Grade | 3995 | 4246 |
| 17 | Western & Southern Mutual Holdings | 7769 | 9488 | AA | All Other |  | 16558 | 15883 | NA | 1665 | 1665 |
| 18 | Province of New Brunswick Canada | 7682 | 8134 | A+ |  | Total | $219870 | $238052 | Total | $192346 | $207011 |
| 19 | Province of British Columbia Canada | 7489 | 7956 | AA+ |  |  |  |  |  |  |  |
| 20 | Province of Newfoundland and Labrador | 7352 | 8214 | A |  |  |  |  |  |  |  |
| 21 | Apple Inc | 7139 | 7708 | AA+ |  |  |  |  |  |  |  |
| 22 | Air Lease Corp | 7055 | 7895 | BBB |  |  |  |  |  |  |  |
| 23 | Tokyo Century Corp | 6968 | 7984 | BBB |  |  |  |  |  |  |  |
| 24 | Booking Holdings Inc | 6939 | 7080 | A- |  |  |  |  |  |  |  |
| 25 | GATX Corp | 6849 | 7538 | BBB |  |  |  |  |  |  |  |
|  | Total | $240333 | $261284 |  |  |  |  |  |  |  |  |
|  | % of total fixed income portfolio | 7.8% | 7.7% |  |  |  |  |  |  |  |  |

---

(1) US$ denominated investments in issuers outside of the United States based on country of risk.

(2) Emerging markets is as defined by MSCI, Inc. which include Chile, India, Peru, Poland and South Africa.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Note: Investment Portfolio pages in this Financial Supplement exclude the Held to Maturity asset on our balance sheet.

17 of 18

------

---

| | |
|:---|:---|
| **Five-Year Historical Key Statistics** | **PRIMERICA, INC.**<br>Financial Supplement |

---

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| (Dollars in millions) | **2018** | **2019** | **2020** | **2021** | **2022** | **Q1<br>2021** | **Q2<br>2021** | **Q3<br>2021** | **Q4<br>2021** | **Q1<br>2022** | **Q2<br>2022** | **Q3<br>2022** | **Q4<br>2022** |
| Recruits | 290886 | 282207 | 400345 | 349374 | 359735 | 94633 | 89285 | 91884 | 73572 | 84707 | 70215 | 127788 | 77025 |
| Life-insurance licensed sales force, beginning of period | 126121 | 130736 | 130522 | 134907 | 129515 | 134907 | 132030 | 132041 | 130023 | 129515 | 130206 | 132149 | 134313 |
| New life-licensed representatives | 48041 | 44739 | 48106 | 39622 | 45147 | 10833 | 10112 | 9381 | 9296 | 9983 | 11529 | 12518 | 11117 |
| Non-renewal and terminated representatives | (43426) | (44953) | (43721) | (45014) | (39454) | (13710) | (10101) | (11399) | (9804) | (9292) | (9586) | (10354) | (10222) |
| Life-insurance licensed sales force, end of period | 130736 | 130522 | 134907 | 129515 | 135208 | 132030 | 132041 | 130023 | 129515 | 130206 | 132149 | 134313 | 135208 |
| Issued term life policies | 301589 | 287809 | 352868 | 323855 | 291918 | 82667 | 90071 | 75914 | 75203 | 71324 | 76946 | 71104 | 72544 |
| Issued term life face amount | $95209 | $93994 | $109436 | $108521 | $103822 | $26643 | $29981 | $26219 | $25678 | $24773 | $27651 | $26049 | $25349 |
| Term life face amount in force, beginning of period | $763831 | $781041 | $808262 | $858818 | $903404 | $858818 | $869643 | $886519 | $894018 | $903404 | $909632 | $914438 | $912785 |
| Issued term life face amount | 95209 | 93994 | 109436 | 108521 | 103822 | 26643 | 29981 | 26219 | 25678 | 24773 | 27651 | 26049 | 25349 |
| Terminated term life face amount | (70291) | (71519) | (60848) | (64798) | (82894) | (17240) | (14706) | (16241) | (16610) | (19787) | (19298) | (21033) | (22776) |
| Foreign currency impact, net | (7708) | 4746 | 1968 | 862 | (7524) | 1422 | 1602 | (2480) | 319 | 1242 | (3547) | (6669) | 1450 |
| Term life face amount in force, end of period | $781041 | $808262 | $858818 | $903404 | $916808 | $869643 | $886519 | $894018 | $903404 | $909632 | $914438 | $912785 | $916808 |
| Estimated annualized issued term life premium |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Premium from new policies | $250.8 | $244.8 | $303.6 | $297.2 | $271.9 | $74.5 | $82.6 | $70.7 | $69.4 | $65.5 | $72.3 | $68.0 | $66.0 |
| Additions and increases in premium | 55.2 | 60.2 | 68.9 | 77.0 | 76.7 | 18.0 | 20.3 | 19.5 | 19.1 | 18.4 | 20.6 | 19.5 | 18.2 |
| Total estimated annualized issued term life premium | $306.0 | $305.0 | $372.5 | $374.2 | $348.5 | $92.5 | $103.0 | $90.2 | $88.5 | $83.8 | $92.9 | $87.5 | $84.2 |
| Investment & Savings product sales | $7040.1 | $7533.2 | $7842.5 | $11703.2 | $10009.0 | $2853.5 | $3040.2 | $2790.4 | $3019.0 | $3065.4 | $2689.6 | $2161.5 | $2092.5 |
| Investment & Savings average client asset values | $61842 | $65029 | $69709 | $89993 | $87193 | $83131 | $89378 | $92652 | $94809 | $94203 | $87994 | $83320 | $83256 |
| Closed U.S. Mortgage Volume (brokered) | $— | $31.1 | $442.5 | $1229.2 | $567.2 | $262.3 | $298.6 | $337.6 | $330.8 | $235.9 | $152.7 | $99.8 | $78.9 |

---

18 of 18

------